<?xml version='1.0' encoding='UTF-8'?><?xml-stylesheet href="http://www.blogger.com/styles/atom.css" type="text/css"?><feed xmlns='http://www.w3.org/2005/Atom' xmlns:openSearch='http://a9.com/-/spec/opensearchrss/1.0/' xmlns:blogger='http://schemas.google.com/blogger/2008' xmlns:georss='http://www.georss.org/georss' xmlns:gd="http://schemas.google.com/g/2005" xmlns:thr='http://purl.org/syndication/thread/1.0'><id>tag:blogger.com,1999:blog-950616212044414228</id><updated>2026-06-16T09:57:50.440-07:00</updated><category term="hipersomnolencia"/><category term="web 2.0. internet"/><category term="patologia"/><category term="poligrafía"/><category term="sueño"/><category term="tecnicas"/><category term="tos"/><category term="EPID"/><category term="FPI"/><category term="Infiltados"/><category term="apneas"/><category term="broncoscopia"/><category term="cansancio"/><category term="cefalea"/><category term="epworth"/><category term="informacion"/><category term="insuficiencia respiratoria"/><category term="intersticial"/><category term="nicturia"/><category term="roncador"/><category term="signos"/><category term="síntomas"/><title type='text'>blogrespira</title><subtitle type='html'>cosas de neumología</subtitle><link rel='http://schemas.google.com/g/2005#feed' type='application/atom+xml' href='http://blogrespira.blogspot.com/feeds/posts/default'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/950616212044414228/posts/default?redirect=false'/><link rel='alternate' type='text/html' href='http://blogrespira.blogspot.com/'/><link rel='hub' href='http://pubsubhubbub.appspot.com/'/><author><name>Raúl</name><uri>http://www.blogger.com/profile/14709690265626598608</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><generator version='7.00' uri='http://www.blogger.com'>Blogger</generator><openSearch:totalResults>15</openSearch:totalResults><openSearch:startIndex>1</openSearch:startIndex><openSearch:itemsPerPage>25</openSearch:itemsPerPage><entry><id>tag:blogger.com,1999:blog-950616212044414228.post-2979405121799326688</id><published>2018-08-06T01:49:00.000-07:00</published><updated>2018-08-06T01:49:10.602-07:00</updated><title type='text'>EXACERBACIÓN DE LA FPI</title><content type='html'>&lt;div class=&quot;MsoNormal&quot; style=&quot;-webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; caret-color: rgb(0, 0, 0); color: black; font-family: Cambria; font-size: medium; font-style: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; line-height: 24px; margin: 0cm 0cm 0.0001pt; orphans: auto; text-align: start; text-decoration: none; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;&quot;&gt;
&lt;span lang=&quot;ES-TRAD&quot;&gt;&amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp;(Este es un extracto de un curso y capítulo que está en realización)&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;-webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; caret-color: rgb(0, 0, 0); color: black; font-family: Cambria; font-size: medium; font-style: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; line-height: 24px; margin: 0cm 0cm 0.0001pt; orphans: auto; text-align: start; text-decoration: none; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;&quot;&gt;
&lt;span lang=&quot;ES-TRAD&quot;&gt;&amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;-webkit-text-stroke-width: 0px; caret-color: rgb(0, 0, 0); color: black; font-family: Cambria; font-style: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; line-height: 24px; margin: 0cm 0cm 0.0001pt; text-align: start; text-decoration: none; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px;&quot;&gt;
&lt;span lang=&quot;ES-TRAD&quot;&gt;&lt;span style=&quot;font-size: small;&quot;&gt;&amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp;&lt;/span&gt;&lt;span style=&quot;font-size: large;&quot;&gt; &amp;nbsp; &amp;nbsp; &amp;nbsp;DEFINICIÓN&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;-webkit-text-stroke-width: 0px; caret-color: rgb(0, 0, 0); color: black; font-family: Cambria; font-style: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; line-height: 24px; margin: 0cm 0cm 0.0001pt 36pt; text-align: start; text-decoration: none; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px;&quot;&gt;
&lt;span style=&quot;font-size: large;&quot;&gt;&lt;span lang=&quot;ES-TRAD&quot;&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/span&gt;&lt;span lang=&quot;ES-TRAD&quot; style=&quot;text-align: justify; text-indent: 36pt;&quot;&gt;La Exacerbación de la Fibrosis Pulmonar Idiopática (FPI) supone un d&lt;/span&gt;&lt;span style=&quot;text-align: justify; text-indent: 36pt;&quot;&gt;eterioro respiratorio agudo que es clínicamente relevante.&amp;nbsp;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;-webkit-text-stroke-width: 0px; caret-color: rgb(0, 0, 0); color: black; font-family: Cambria; font-style: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; line-height: 24px; margin: 0cm 0cm 0.0001pt; text-align: justify; text-decoration: none; text-indent: 36pt; text-transform: none; white-space: normal; word-spacing: 0px;&quot;&gt;
&lt;span&gt;&lt;span style=&quot;font-size: large;&quot;&gt;En un principio había que descartar cualquier causa identificable, pero veremos que eso está puesto en duda, en cualquier caso si hay que descartar una serie de causas (por ejemplo la insuficiencia cardíaca) como se verá posteriormente.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;-webkit-text-stroke-width: 0px; caret-color: rgb(0, 0, 0); color: black; font-family: Cambria; font-style: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; line-height: 24px; margin: 0cm 0cm 0.0001pt 36pt; text-align: start; text-decoration: none; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px;&quot;&gt;
&lt;span style=&quot;font-size: large;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;-webkit-text-stroke-width: 0px; caret-color: rgb(0, 0, 0); color: black; font-family: Cambria; font-style: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; line-height: 24px; margin: 0cm 0cm 0.0001pt 36pt; text-align: start; text-decoration: none; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px;&quot;&gt;
&lt;span lang=&quot;ES-TRAD&quot;&gt;&lt;span style=&quot;font-size: large;&quot;&gt;IMPORTANCIA DE LAS EXACERBACIONES&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;-webkit-text-stroke-width: 0px; caret-color: rgb(0, 0, 0); color: black; font-family: Cambria; font-style: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; line-height: 24px; margin: 0cm 0cm 0.0001pt; text-align: justify; text-decoration: none; text-indent: 35.45pt; text-transform: none; white-space: normal; word-spacing: 0px;&quot;&gt;
&lt;span&gt;&lt;span style=&quot;font-size: large;&quot;&gt;La supervivencia media tras la exacerbación es de 3-4 meses y la mortalidad intrahospitalaria mayor del 50% por la insuficiencia respiratoria que se produce.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;-webkit-text-stroke-width: 0px; caret-color: rgb(0, 0, 0); color: black; font-family: Cambria; font-style: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; line-height: 24px; margin: 0cm 0cm 0.0001pt; text-align: justify; text-decoration: none; text-indent: 36pt; text-transform: none; white-space: normal; word-spacing: 0px;&quot;&gt;
&lt;span&gt;&lt;span style=&quot;font-size: large;&quot;&gt;Además más del 46% de las muertes en FPI están precedidas por una exacerbación.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;-webkit-text-stroke-width: 0px; caret-color: rgb(0, 0, 0); color: black; font-family: Cambria; font-style: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; line-height: 24px; margin: 0cm 0cm 0.0001pt 36pt; text-align: start; text-decoration: none; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;-webkit-text-stroke-width: 0px; caret-color: rgb(0, 0, 0); color: black; font-family: Cambria; font-style: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; line-height: 24px; margin: 0cm 0cm 0.0001pt 36pt; text-align: start; text-decoration: none; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px;&quot;&gt;
&lt;span lang=&quot;ES-TRAD&quot;&gt;&lt;span style=&quot;font-size: large;&quot;&gt;ETIOLOGÍA&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;-webkit-text-stroke-width: 0px; caret-color: rgb(0, 0, 0); color: black; font-family: Cambria; font-style: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; line-height: 24px; margin: 0cm 0cm 0.0001pt; text-align: start; text-decoration: none; text-indent: 35.4pt; text-transform: none; white-space: normal; word-spacing: 0px;&quot;&gt;
&lt;span&gt;&lt;span style=&quot;font-size: large;&quot;&gt;Se sabe que tienen mayor riesgo los pacientes con :&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;-webkit-text-stroke-width: 0px; caret-color: rgb(0, 0, 0); color: black; font-family: Cambria; font-style: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; line-height: 24px; margin: 0cm 0cm 0.0001pt 36pt; text-align: start; text-decoration: none; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px;&quot;&gt;
&lt;span&gt;&lt;span style=&quot;font-size: large;&quot;&gt;1- Capacidad Vital Forzada (FVC) baja (enfermedad avanzada)&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;-webkit-text-stroke-width: 0px; caret-color: rgb(0, 0, 0); color: black; font-family: Cambria; font-style: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; line-height: 24px; margin: 0cm 0cm 0.0001pt; text-align: start; text-decoration: none; text-indent: 36pt; text-transform: none; white-space: normal; word-spacing: 0px;&quot;&gt;
&lt;span&gt;&lt;span style=&quot;font-size: large;&quot;&gt;2- Disminución de la difusión (DLCO), test de la marcha, oxigenación basal e hipertensión pulmonar&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;-webkit-text-stroke-width: 0px; caret-color: rgb(0, 0, 0); color: black; font-family: Cambria; font-style: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; line-height: 24px; margin: 0cm 0cm 0.0001pt 36pt; text-align: start; text-decoration: none; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px;&quot;&gt;
&lt;span style=&quot;font-size: large;&quot;&gt;&lt;span&gt;3- Más jóvenes&lt;/span&gt;&lt;span lang=&quot;ES-TRAD&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;-webkit-text-stroke-width: 0px; caret-color: rgb(0, 0, 0); color: black; font-family: Cambria; font-style: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; line-height: 24px; margin: 0cm 0cm 0.0001pt; text-align: start; text-decoration: none; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;-webkit-text-stroke-width: 0px; caret-color: rgb(0, 0, 0); color: black; font-family: Cambria; font-style: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; line-height: 24px; margin: 0cm 0cm 0.0001pt; text-align: start; text-decoration: none; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px;&quot;&gt;
&lt;span&gt;&lt;span style=&quot;font-size: large;&quot;&gt;&lt;span&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/span&gt;CRITERIOS DIAGNÓSTICOS&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;-webkit-text-stroke-width: 0px; caret-color: rgb(0, 0, 0); color: black; font-family: Cambria; font-style: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; line-height: 24px; margin: 0cm 0cm 0.0001pt; text-align: start; text-decoration: none; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px;&quot;&gt;
&lt;span style=&quot;font-size: large;&quot;&gt;&lt;span&gt;&lt;span&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/span&gt;&lt;/span&gt;&lt;span style=&quot;text-align: justify; text-indent: 18pt;&quot;&gt;Se produciría un deterioro respiratorio agudo de menos de un mes de duración con alteraciones alveolares dispersas.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;-webkit-text-stroke-width: 0px; caret-color: rgb(0, 0, 0); color: black; font-family: Cambria; font-style: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; line-height: 24px; margin: 0cm 0cm 0.0001pt; text-align: justify; text-decoration: none; text-indent: 18pt; text-transform: none; white-space: normal; word-spacing: 0px;&quot;&gt;
&lt;span&gt;&lt;span style=&quot;font-size: large;&quot;&gt;Los criterios serían:&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: 150%; margin-left: 72.0pt; mso-list: l2 level2 lfo3; tab-stops: list 72.0pt; text-align: justify; text-indent: -18.0pt; text-justify: inter-ideograph;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-size: large;&quot;&gt;&lt;span style=&quot;font-family: Times; mso-ansi-language: ES; mso-bidi-font-family: Times; mso-fareast-font-family: Times;&quot;&gt;&lt;span style=&quot;mso-list: Ignore;&quot;&gt;-&lt;span style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;; font-stretch: normal; font-style: normal; font-variant-caps: normal; font-weight: normal; line-height: normal;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span&gt;Diagnóstico FPI (previo o simultáneo)&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: 150%; margin-left: 72.0pt; mso-list: l2 level2 lfo3; tab-stops: list 72.0pt; text-align: justify; text-indent: -18.0pt; text-justify: inter-ideograph;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-size: large;&quot;&gt;&lt;span style=&quot;font-family: Times; mso-ansi-language: ES; mso-bidi-font-family: Times; mso-fareast-font-family: Times;&quot;&gt;&lt;span style=&quot;mso-list: Ignore;&quot;&gt;-&lt;span style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;; font-stretch: normal; font-style: normal; font-variant-caps: normal; font-weight: normal; line-height: normal;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span&gt;Disnea de menos de un mes de evolución&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: 150%; margin-left: 14.2pt; mso-list: l2 level2 lfo3; tab-stops: list 35.45pt; text-align: justify; text-indent: 39.8pt; text-justify: inter-ideograph;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-size: large;&quot;&gt;&lt;span style=&quot;font-family: Times; mso-ansi-language: ES; mso-bidi-font-family: Times; mso-fareast-font-family: Times;&quot;&gt;&lt;span style=&quot;mso-list: Ignore;&quot;&gt;-&lt;span style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;; font-stretch: normal; font-style: normal; font-variant-caps: normal; font-weight: normal; line-height: normal;&quot;&gt;&amp;nbsp;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span&gt;TACAR con vidrio deslustrado bilateral y/o consolidaciones sobre patrón de NIU preexistente&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: 150%; margin-left: 14.2pt; mso-list: l2 level2 lfo3; tab-stops: list 42.55pt; text-align: justify; text-indent: 39.8pt; text-justify: inter-ideograph;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-size: large;&quot;&gt;&lt;span style=&quot;font-family: Times; mso-ansi-language: ES; mso-bidi-font-family: Times; mso-fareast-font-family: Times;&quot;&gt;&lt;span style=&quot;mso-list: Ignore;&quot;&gt;-&lt;span style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;; font-stretch: normal; font-style: normal; font-variant-caps: normal; font-weight: normal; line-height: normal;&quot;&gt;&amp;nbsp; D&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span&gt;eterioro no explicado por sobrecarga hídrica o insuficiencia cardíaca&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;-webkit-text-stroke-width: 0px; caret-color: rgb(0, 0, 0); color: black; font-family: Cambria; font-style: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; line-height: 24px; margin: 0cm 0cm 0.0001pt; text-align: justify; text-decoration: none; text-indent: 36pt; text-transform: none; white-space: normal; word-spacing: 0px;&quot;&gt;
&lt;span style=&quot;font-size: large;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;-webkit-text-stroke-width: 0px; caret-color: rgb(0, 0, 0); color: black; font-family: Cambria; font-style: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; line-height: 24px; margin: 0cm 0cm 0.0001pt; text-align: justify; text-decoration: none; text-indent: 36pt; text-transform: none; white-space: normal; word-spacing: 0px;&quot;&gt;
&lt;span&gt;&lt;span style=&quot;font-size: large;&quot;&gt;TRATAMIENTO&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;-webkit-text-stroke-width: 0px; caret-color: rgb(0, 0, 0); color: black; font-family: Cambria; font-style: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; line-height: 24px; margin: 0cm 0cm 0.0001pt; text-align: justify; text-decoration: none; text-indent: 36pt; text-transform: none; white-space: normal; word-spacing: 0px;&quot;&gt;
&lt;span style=&quot;font-size: large;&quot;&gt;&lt;span lang=&quot;ES-TRAD&quot;&gt;Se utilizan los c&lt;b&gt;ortoicoides&amp;nbsp;&lt;/b&gt;con dosis&lt;/span&gt;&lt;span lang=&quot;ES-TRAD&quot;&gt;&lt;span&gt;&amp;nbsp;&lt;/span&gt;de 250-1000 gramos/día durante 3 días, seguido de prednisona a 0,5 mg/kg/día.&lt;span&gt;&amp;nbsp;&amp;nbsp;&lt;/span&gt;&lt;/span&gt;&lt;span&gt;No hay ensayos clínicos controlados y la evidencia científica para esta recomendación es débil.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;-webkit-text-stroke-width: 0px; caret-color: rgb(0, 0, 0); color: black; font-family: Cambria; font-style: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; line-height: 24px; margin: 0cm 0cm 0.0001pt; text-align: justify; text-decoration: none; text-indent: 36pt; text-transform: none; white-space: normal; word-spacing: 0px;&quot;&gt;
&lt;span style=&quot;font-size: large;&quot;&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;-webkit-text-stroke-width: 0px; caret-color: rgb(0, 0, 0); color: black; font-family: Cambria; font-style: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; line-height: 24px; margin: 0cm 0cm 0.0001pt; text-align: justify; text-decoration: none; text-indent: 36pt; text-transform: none; white-space: normal; word-spacing: 0px;&quot;&gt;
&lt;span&gt;&lt;span style=&quot;font-size: large;&quot;&gt;El tratamiento paliativo es muy importante para el control de síntomas como la disnea y la tos..&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;-webkit-text-stroke-width: 0px; caret-color: rgb(0, 0, 0); color: black; font-family: Cambria; font-style: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; line-height: 24px; margin: 0cm 0cm 0.0001pt; text-align: justify; text-decoration: none; text-indent: 35.4pt; text-transform: none; white-space: normal; word-spacing: 0px;&quot;&gt;
&lt;span&gt;&lt;span style=&quot;font-size: large;&quot;&gt;Medidas preventivas son:&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;-webkit-text-stroke-width: 0px; caret-color: rgb(0, 0, 0); color: black; font-family: Cambria; font-style: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; line-height: 24px; margin: 0cm 0cm 0.0001pt 35.4pt; text-align: justify; text-decoration: none; text-indent: 18.6pt; text-transform: none; white-space: normal; word-spacing: 0px;&quot;&gt;
&lt;span style=&quot;font-size: large;&quot;&gt;&lt;span&gt;-&lt;span&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/span&gt;Uso de a&lt;/span&gt;&lt;span&gt;ntifibróticos (pirfenidona o nintedanib)&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: 150%; margin-left: 72.0pt; mso-list: l3 level2 lfo4; tab-stops: list 72.0pt; text-align: justify; text-indent: -18.0pt; text-justify: inter-ideograph;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-size: large;&quot;&gt;&lt;span style=&quot;font-family: Times; mso-ansi-language: ES; mso-bidi-font-family: Times; mso-fareast-font-family: Times;&quot;&gt;&lt;span style=&quot;mso-list: Ignore;&quot;&gt;-&lt;span style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;; font-stretch: normal; font-style: normal; font-variant-caps: normal; font-weight: normal; line-height: normal;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span&gt;Vacunación antigripal y antineumocócica&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: 150%; margin-left: 72.0pt; mso-list: l3 level2 lfo4; tab-stops: list 72.0pt; text-align: justify; text-indent: -18.0pt; text-justify: inter-ideograph;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-size: large;&quot;&gt;&lt;span style=&quot;font-family: Times; mso-ansi-language: ES; mso-bidi-font-family: Times; mso-fareast-font-family: Times;&quot;&gt;&lt;span style=&quot;mso-list: Ignore;&quot;&gt;-&lt;span style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;; font-stretch: normal; font-style: normal; font-variant-caps: normal; font-weight: normal; line-height: normal;&quot;&gt;&amp;nbsp; &amp;nbsp; T&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span&gt;ratamiento para el reflujo gastroesofágico.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;style class=&quot;WebKit-mso-list-quirks-style&quot;&gt;
&lt;!--
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
 {mso-style-unhide:no;
 mso-style-qformat:yes;
 mso-style-parent:&quot;&quot;;
 margin:0cm;
 margin-bottom:.0001pt;
 mso-pagination:widow-orphan;
 font-size:12.0pt;
 font-family:Cambria;
 mso-ascii-font-family:Cambria;
 mso-ascii-theme-font:minor-latin;
 mso-fareast-font-family:&quot;ＭＳ 明朝&quot;;
 mso-fareast-theme-font:minor-fareast;
 mso-hansi-font-family:Cambria;
 mso-hansi-theme-font:minor-latin;
 mso-bidi-font-family:&quot;Times New Roman&quot;;
 mso-bidi-theme-font:minor-bidi;
 mso-ansi-language:ES-TRAD;}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
 {mso-style-priority:34;
 mso-style-unhide:no;
 mso-style-qformat:yes;
 margin-top:0cm;
 margin-right:0cm;
 margin-bottom:0cm;
 margin-left:36.0pt;
 margin-bottom:.0001pt;
 mso-add-space:auto;
 mso-pagination:widow-orphan;
 font-size:10.0pt;
 font-family:Times;
 mso-fareast-font-family:&quot;ＭＳ 明朝&quot;;
 mso-fareast-theme-font:minor-fareast;
 mso-bidi-font-family:&quot;Times New Roman&quot;;
 mso-bidi-theme-font:minor-bidi;}
p.MsoListParagraphCxSpFirst, li.MsoListParagraphCxSpFirst, div.MsoListParagraphCxSpFirst
 {mso-style-priority:34;
 mso-style-unhide:no;
 mso-style-qformat:yes;
 mso-style-type:export-only;
 margin-top:0cm;
 margin-right:0cm;
 margin-bottom:0cm;
 margin-left:36.0pt;
 margin-bottom:.0001pt;
 mso-add-space:auto;
 mso-pagination:widow-orphan;
 font-size:10.0pt;
 font-family:Times;
 mso-fareast-font-family:&quot;ＭＳ 明朝&quot;;
 mso-fareast-theme-font:minor-fareast;
 mso-bidi-font-family:&quot;Times New Roman&quot;;
 mso-bidi-theme-font:minor-bidi;}
p.MsoListParagraphCxSpMiddle, li.MsoListParagraphCxSpMiddle, div.MsoListParagraphCxSpMiddle
 {mso-style-priority:34;
 mso-style-unhide:no;
 mso-style-qformat:yes;
 mso-style-type:export-only;
 margin-top:0cm;
 margin-right:0cm;
 margin-bottom:0cm;
 margin-left:36.0pt;
 margin-bottom:.0001pt;
 mso-add-space:auto;
 mso-pagination:widow-orphan;
 font-size:10.0pt;
 font-family:Times;
 mso-fareast-font-family:&quot;ＭＳ 明朝&quot;;
 mso-fareast-theme-font:minor-fareast;
 mso-bidi-font-family:&quot;Times New Roman&quot;;
 mso-bidi-theme-font:minor-bidi;}
p.MsoListParagraphCxSpLast, li.MsoListParagraphCxSpLast, div.MsoListParagraphCxSpLast
 {mso-style-priority:34;
 mso-style-unhide:no;
 mso-style-qformat:yes;
 mso-style-type:export-only;
 margin-top:0cm;
 margin-right:0cm;
 margin-bottom:0cm;
 margin-left:36.0pt;
 margin-bottom:.0001pt;
 mso-add-space:auto;
 mso-pagination:widow-orphan;
 font-size:10.0pt;
 font-family:Times;
 mso-fareast-font-family:&quot;ＭＳ 明朝&quot;;
 mso-fareast-theme-font:minor-fareast;
 mso-bidi-font-family:&quot;Times New Roman&quot;;
 mso-bidi-theme-font:minor-bidi;}
.MsoChpDefault
 {mso-style-type:export-only;
 mso-default-props:yes;
 font-family:Cambria;
 mso-ascii-font-family:Cambria;
 mso-ascii-theme-font:minor-latin;
 mso-fareast-font-family:&quot;ＭＳ 明朝&quot;;
 mso-fareast-theme-font:minor-fareast;
 mso-hansi-font-family:Cambria;
 mso-hansi-theme-font:minor-latin;
 mso-bidi-font-family:&quot;Times New Roman&quot;;
 mso-bidi-theme-font:minor-bidi;
 mso-ansi-language:ES-TRAD;}
@page WordSection1
 {size:612.0pt 792.0pt;
 margin:70.85pt 3.0cm 70.85pt 3.0cm;
 mso-header-margin:36.0pt;
 mso-footer-margin:36.0pt;
 mso-paper-source:0;}
div.WordSection1
 {page:WordSection1;}
 /* List Definitions */
@list l0
 {mso-list-id:90274831;
 mso-list-type:hybrid;
 mso-list-template-ids:1311147380 1001799432 -2059770358 -24857350 1324940700 296116428 -613893106 373829944 -1357096970 -115974472;}
@list l0:level1
 {mso-level-number-format:bullet;
 mso-level-text:-;
 mso-level-tab-stop:88.8pt;
 mso-level-number-position:left;
 margin-left:88.8pt;
 text-indent:-18.0pt;
 font-family:Times;}
@list l0:level2
 {mso-level-number-format:bullet;
 mso-level-text:-;
 mso-level-tab-stop:124.8pt;
 mso-level-number-position:left;
 margin-left:124.8pt;
 text-indent:-18.0pt;
 font-family:Times;}
@list l0:level3
 {mso-level-start-at:0;
 mso-level-number-format:bullet;
 mso-level-text:-;
 mso-level-tab-stop:160.8pt;
 mso-level-number-position:left;
 margin-left:160.8pt;
 text-indent:-18.0pt;
 font-family:Times;}
@list l0:level4
 {mso-level-number-format:bullet;
 mso-level-text:-;
 mso-level-tab-stop:196.8pt;
 mso-level-number-position:left;
 margin-left:196.8pt;
 text-indent:-18.0pt;
 font-family:Times;}
@list l0:level5
 {mso-level-number-format:bullet;
 mso-level-text:-;
 mso-level-tab-stop:232.8pt;
 mso-level-number-position:left;
 margin-left:232.8pt;
 text-indent:-18.0pt;
 font-family:Times;}
@list l0:level6
 {mso-level-number-format:bullet;
 mso-level-text:-;
 mso-level-tab-stop:268.8pt;
 mso-level-number-position:left;
 margin-left:268.8pt;
 text-indent:-18.0pt;
 font-family:Times;}
@list l0:level7
 {mso-level-number-format:bullet;
 mso-level-text:-;
 mso-level-tab-stop:304.8pt;
 mso-level-number-position:left;
 margin-left:304.8pt;
 text-indent:-18.0pt;
 font-family:Times;}
@list l0:level8
 {mso-level-number-format:bullet;
 mso-level-text:-;
 mso-level-tab-stop:340.8pt;
 mso-level-number-position:left;
 margin-left:340.8pt;
 text-indent:-18.0pt;
 font-family:Times;}
@list l0:level9
 {mso-level-number-format:bullet;
 mso-level-text:-;
 mso-level-tab-stop:376.8pt;
 mso-level-number-position:left;
 margin-left:376.8pt;
 text-indent:-18.0pt;
 font-family:Times;}
@list l1
 {mso-list-id:323554374;
 mso-list-type:hybrid;
 mso-list-template-ids:-122381648 -904889630 -1402429660 -1291424972 345683860 1472643148 -1379078154 1120958628 -1759581288 -340081004;}
@list l1:level1
 {mso-level-number-format:bullet;
 mso-level-text:-;
 mso-level-tab-stop:36.0pt;
 mso-level-number-position:left;
 text-indent:-18.0pt;
 font-family:Times;}
@list l1:level2
 {mso-level-start-at:0;
 mso-level-number-format:bullet;
 mso-level-text:-;
 mso-level-tab-stop:72.0pt;
 mso-level-number-position:left;
 text-indent:-18.0pt;
 font-family:Times;}
@list l1:level3
 {mso-level-number-format:bullet;
 mso-level-text:-;
 mso-level-tab-stop:108.0pt;
 mso-level-number-position:left;
 text-indent:-18.0pt;
 font-family:Times;}
@list l1:level4
 {mso-level-number-format:bullet;
 mso-level-text:-;
 mso-level-tab-stop:144.0pt;
 mso-level-number-position:left;
 text-indent:-18.0pt;
 font-family:Times;}
@list l1:level5
 {mso-level-number-format:bullet;
 mso-level-text:-;
 mso-level-tab-stop:180.0pt;
 mso-level-number-position:left;
 text-indent:-18.0pt;
 font-family:Times;}
@list l1:level6
 {mso-level-number-format:bullet;
 mso-level-text:-;
 mso-level-tab-stop:216.0pt;
 mso-level-number-position:left;
 text-indent:-18.0pt;
 font-family:Times;}
@list l1:level7
 {mso-level-number-format:bullet;
 mso-level-text:-;
 mso-level-tab-stop:252.0pt;
 mso-level-number-position:left;
 text-indent:-18.0pt;
 font-family:Times;}
@list l1:level8
 {mso-level-number-format:bullet;
 mso-level-text:-;
 mso-level-tab-stop:288.0pt;
 mso-level-number-position:left;
 text-indent:-18.0pt;
 font-family:Times;}
@list l1:level9
 {mso-level-number-format:bullet;
 mso-level-text:-;
 mso-level-tab-stop:324.0pt;
 mso-level-number-position:left;
 text-indent:-18.0pt;
 font-family:Times;}
@list l2
 {mso-list-id:1002971404;
 mso-list-type:hybrid;
 mso-list-template-ids:-520159820 -2057922186 -335667758 1735969696 1046801032 -464483024 -387934080 -7668576 751624942 1267357496;}
@list l2:level1
 {mso-level-number-format:bullet;
 mso-level-text:-;
 mso-level-tab-stop:36.0pt;
 mso-level-number-position:left;
 text-indent:-18.0pt;
 font-family:Times;}
@list l2:level2
 {mso-level-start-at:0;
 mso-level-number-format:bullet;
 mso-level-text:-;
 mso-level-tab-stop:72.0pt;
 mso-level-number-position:left;
 text-indent:-18.0pt;
 font-family:Times;}
@list l2:level3
 {mso-level-number-format:bullet;
 mso-level-text:-;
 mso-level-tab-stop:108.0pt;
 mso-level-number-position:left;
 text-indent:-18.0pt;
 font-family:Times;}
@list l2:level4
 {mso-level-number-format:bullet;
 mso-level-text:-;
 mso-level-tab-stop:144.0pt;
 mso-level-number-position:left;
 text-indent:-18.0pt;
 font-family:Times;}
@list l2:level5
 {mso-level-number-format:bullet;
 mso-level-text:-;
 mso-level-tab-stop:180.0pt;
 mso-level-number-position:left;
 text-indent:-18.0pt;
 font-family:Times;}
@list l2:level6
 {mso-level-number-format:bullet;
 mso-level-text:-;
 mso-level-tab-stop:216.0pt;
 mso-level-number-position:left;
 text-indent:-18.0pt;
 font-family:Times;}
@list l2:level7
 {mso-level-number-format:bullet;
 mso-level-text:-;
 mso-level-tab-stop:252.0pt;
 mso-level-number-position:left;
 text-indent:-18.0pt;
 font-family:Times;}
@list l2:level8
 {mso-level-number-format:bullet;
 mso-level-text:-;
 mso-level-tab-stop:288.0pt;
 mso-level-number-position:left;
 text-indent:-18.0pt;
 font-family:Times;}
@list l2:level9
 {mso-level-number-format:bullet;
 mso-level-text:-;
 mso-level-tab-stop:324.0pt;
 mso-level-number-position:left;
 text-indent:-18.0pt;
 font-family:Times;}
@list l3
 {mso-list-id:1222328378;
 mso-list-type:hybrid;
 mso-list-template-ids:1770976452 -2069471324 -1306768978 -326336372 45892212 -858484326 1669134418 446751998 1961543860 1345222024;}
@list l3:level1
 {mso-level-number-format:bullet;
 mso-level-text:-;
 mso-level-tab-stop:36.0pt;
 mso-level-number-position:left;
 text-indent:-18.0pt;
 font-family:Times;}
@list l3:level2
 {mso-level-start-at:0;
 mso-level-number-format:bullet;
 mso-level-text:-;
 mso-level-tab-stop:72.0pt;
 mso-level-number-position:left;
 text-indent:-18.0pt;
 font-family:Times;}
@list l3:level3
 {mso-level-number-format:bullet;
 mso-level-text:-;
 mso-level-tab-stop:108.0pt;
 mso-level-number-position:left;
 text-indent:-18.0pt;
 font-family:Times;}
@list l3:level4
 {mso-level-number-format:bullet;
 mso-level-text:-;
 mso-level-tab-stop:144.0pt;
 mso-level-number-position:left;
 text-indent:-18.0pt;
 font-family:Times;}
@list l3:level5
 {mso-level-number-format:bullet;
 mso-level-text:-;
 mso-level-tab-stop:180.0pt;
 mso-level-number-position:left;
 text-indent:-18.0pt;
 font-family:Times;}
@list l3:level6
 {mso-level-number-format:bullet;
 mso-level-text:-;
 mso-level-tab-stop:216.0pt;
 mso-level-number-position:left;
 text-indent:-18.0pt;
 font-family:Times;}
@list l3:level7
 {mso-level-number-format:bullet;
 mso-level-text:-;
 mso-level-tab-stop:252.0pt;
 mso-level-number-position:left;
 text-indent:-18.0pt;
 font-family:Times;}
@list l3:level8
 {mso-level-number-format:bullet;
 mso-level-text:-;
 mso-level-tab-stop:288.0pt;
 mso-level-number-position:left;
 text-indent:-18.0pt;
 font-family:Times;}
@list l3:level9
 {mso-level-number-format:bullet;
 mso-level-text:-;
 mso-level-tab-stop:324.0pt;
 mso-level-number-position:left;
 text-indent:-18.0pt;
 font-family:Times;}

--&gt;
&lt;/style&gt;&lt;br /&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: 150%; margin-left: 72.0pt; mso-list: l3 level2 lfo4; tab-stops: list 72.0pt; text-align: justify; text-indent: -18.0pt; text-justify: inter-ideograph;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-size: large;&quot;&gt;&lt;span style=&quot;font-family: Times; mso-ansi-language: ES; mso-bidi-font-family: Times; mso-fareast-font-family: Times;&quot;&gt;-&lt;span style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;; font-stretch: normal; line-height: normal;&quot;&gt;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;Hábitos saludables (Evitar tabaco y polución, evitar exposiciones)&lt;/span&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: 150%; margin-left: 72.0pt; mso-list: l3 level2 lfo4; tab-stops: list 72.0pt; text-align: justify; text-indent: -18.0pt; text-justify: inter-ideograph;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;-webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; caret-color: rgb(0, 0, 0); color: black; font-family: Cambria; font-size: medium; font-style: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; line-height: 24px; margin: 0cm 0cm 0.0001pt 35.4pt; orphans: auto; text-align: start; text-decoration: none; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px;&quot;&gt;
&lt;span&gt;BIBLIOGRAFÍA&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div style=&quot;line-height: 150%; margin-left: 0cm; mso-list: l0 level1 lfo1; tab-stops: list 0cm; text-align: justify; text-indent: 0cm; text-justify: inter-ideograph;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-size: 12.0pt; line-height: 150%; mso-bidi-font-family: Times; mso-fareast-font-family: Times;&quot;&gt;&lt;span style=&quot;mso-list: Ignore;&quot;&gt;-&lt;span style=&quot;font: 7.0pt &amp;quot;Times New Roman&amp;quot;;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;font-family: Cambria; font-size: 12pt; line-height: 24px;&quot;&gt;Collard HR, Yow E, Richeldi L, Amstrong KJ, Glazer C. (2013). Suspected acute exacerbation of idiopathic pulmonary fibrosis as an outcome measure in clinical trials.&amp;nbsp;&lt;i&gt;Respiratory Research&lt;/i&gt;,&amp;nbsp;&lt;i&gt;14&lt;/i&gt;, 73. Retrieved from&amp;nbsp;&lt;/span&gt;&lt;a href=&quot;http://ovidsp.ovid.com/ovidweb.cgi?T=JS&amp;amp;PAGE=reference&amp;amp;D=emed11&amp;amp;NEWS=N&amp;amp;AN=23848435&quot; style=&quot;color: purple; text-decoration: underline;&quot;&gt;&lt;span style=&quot;font-family: Cambria; font-size: 12pt; line-height: 24px;&quot;&gt;http://ovidsp.ovid.com/ovidweb.cgi?T=JS&amp;amp;PAGE=reference&amp;amp;D=emed11&amp;amp;NEWS=N&amp;amp;AN=23848435&lt;/span&gt;&lt;/a&gt;&lt;span style=&quot;font-family: Cambria; font-size: 12pt; line-height: 24px;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div style=&quot;line-height: 150%; margin-left: 0cm; mso-list: l0 level1 lfo1; tab-stops: list 0cm 36.0pt; text-align: justify; text-indent: 0cm; text-justify: inter-ideograph;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-size: 12.0pt; line-height: 150%; mso-bidi-font-family: Times; mso-fareast-font-family: Times;&quot;&gt;&lt;span style=&quot;mso-list: Ignore;&quot;&gt;-&lt;span style=&quot;font: 7.0pt &amp;quot;Times New Roman&amp;quot;;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;font-family: Cambria; font-size: 12pt; line-height: 24px;&quot;&gt;Collard, H. R., Moore, B. B., Flaherty, K. R., Brown, K. K., Kaner, R. J., King Jr, T. E, et al.&lt;span&gt;&amp;nbsp;&amp;nbsp;&lt;/span&gt;(2007). Acute Exacerbations of Idiopathic Pulmonary Fibrosis.&amp;nbsp;&lt;i&gt;Am J Respir Crit Care Med.&lt;/i&gt;,&amp;nbsp;&lt;i&gt;176&lt;/i&gt;(7), 636–43.&amp;nbsp;&lt;/span&gt;&lt;a href=&quot;http://doi.org/10.1164/rccm.200703-463PP&quot; style=&quot;color: purple; text-decoration: underline;&quot;&gt;&lt;span style=&quot;font-family: Cambria; font-size: 12pt; line-height: 24px;&quot;&gt;http://doi.org/10.1164/rccm.200703-463PP&lt;/span&gt;&lt;/a&gt;&lt;span style=&quot;font-family: Cambria; font-size: 12pt; line-height: 24px;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div style=&quot;line-height: 150%; margin-left: 0cm; mso-list: l0 level1 lfo1; tab-stops: list 0cm 36.0pt; text-align: justify; text-indent: 0cm; text-justify: inter-ideograph;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-size: 12.0pt; line-height: 150%; mso-bidi-font-family: Times; mso-fareast-font-family: Times;&quot;&gt;&lt;span style=&quot;mso-list: Ignore;&quot;&gt;-&lt;span style=&quot;font: 7.0pt &amp;quot;Times New Roman&amp;quot;;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;font-family: Cambria; font-size: 12pt; line-height: 24px;&quot;&gt;Raghu, G., Collard, H. R., Egan, J. J., Martinez, F. J., Behr, J., Brown, K. K., et al.(2011). An Official ATS/ERS/JRS/ALAT Statement: Idiopathic pulmonary fibrosis: Evidence-based guidelines for diagnosis and management.&amp;nbsp;&lt;i&gt;American Journal of Respiratory and Critical Care Medicine&lt;/i&gt;,&amp;nbsp;&lt;i&gt;183&lt;/i&gt;(6), 788–824.&amp;nbsp;&lt;/span&gt;&lt;a href=&quot;http://doi.org/10.1164/rccm.2009-040GL&quot; style=&quot;color: purple; text-decoration: underline;&quot;&gt;&lt;span style=&quot;font-family: Cambria; font-size: 12pt; line-height: 24px;&quot;&gt;http://doi.org/10.1164/rccm.2009-040GL&lt;/span&gt;&lt;/a&gt;&lt;span style=&quot;font-family: Cambria; font-size: 12pt; line-height: 24px;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div style=&quot;line-height: 150%; margin-left: 0cm; mso-list: l0 level1 lfo1; tab-stops: list 0cm 36.0pt; text-align: justify; text-indent: 0cm; text-justify: inter-ideograph;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-size: 12.0pt; line-height: 150%; mso-bidi-font-family: Times; mso-fareast-font-family: Times;&quot;&gt;&lt;span style=&quot;mso-list: Ignore;&quot;&gt;-&lt;span style=&quot;font: 7.0pt &amp;quot;Times New Roman&amp;quot;;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;font-family: Cambria; font-size: 12pt; line-height: 24px;&quot;&gt;Xaubet, A., Ancochea, J., Bollo, E., Fernández-Fabrellas, E., Franquet, T., et al (2013). Normativa sobre el diagnóstico y tratamiento de la fibrosis pulmonar idiopática Guidelines for the Diagnosis and Treatment of Idiopathic Pulmonary Fibrosis.&amp;nbsp;&lt;i&gt;Arch Bronconeumol&lt;/i&gt;,&amp;nbsp;&lt;i&gt;49&lt;/i&gt;(8), 343–353.&amp;nbsp;&lt;/span&gt;&lt;a href=&quot;http://doi.org/10.1016/j.arbres.2013.03.011&quot; style=&quot;color: purple; text-decoration: underline;&quot;&gt;&lt;span style=&quot;font-family: Cambria; font-size: 12pt; line-height: 24px;&quot;&gt;http://doi.org/10.1016/j.arbres.2013.03.011&lt;/span&gt;&lt;/a&gt;&lt;span style=&quot;font-family: Cambria; font-size: 12pt; line-height: 24px;&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;line-height: 150%; margin-left: 72.0pt; mso-list: l3 level2 lfo4; tab-stops: list 72.0pt; text-align: justify; text-indent: -18.0pt; text-justify: inter-ideograph;&quot;&gt;
&lt;style class=&quot;WebKit-mso-list-quirks-style&quot;&gt;
&lt;!--
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
 {mso-style-unhide:no;
 mso-style-qformat:yes;
 mso-style-parent:&quot;&quot;;
 margin:0cm;
 margin-bottom:.0001pt;
 mso-pagination:widow-orphan;
 font-size:12.0pt;
 font-family:Cambria;
 mso-ascii-font-family:Cambria;
 mso-ascii-theme-font:minor-latin;
 mso-fareast-font-family:&quot;ＭＳ 明朝&quot;;
 mso-fareast-theme-font:minor-fareast;
 mso-hansi-font-family:Cambria;
 mso-hansi-theme-font:minor-latin;
 mso-bidi-font-family:&quot;Times New Roman&quot;;
 mso-bidi-theme-font:minor-bidi;
 mso-ansi-language:ES-TRAD;}
a:link, span.MsoHyperlink
 {mso-style-priority:99;
 color:blue;
 mso-themecolor:hyperlink;
 text-decoration:underline;
 text-underline:single;}
a:visited, span.MsoHyperlinkFollowed
 {mso-style-noshow:yes;
 mso-style-priority:99;
 color:purple;
 mso-themecolor:followedhyperlink;
 text-decoration:underline;
 text-underline:single;}
p
 {mso-style-noshow:yes;
 mso-style-priority:99;
 mso-margin-top-alt:auto;
 margin-right:0cm;
 mso-margin-bottom-alt:auto;
 margin-left:0cm;
 mso-pagination:widow-orphan;
 font-size:10.0pt;
 font-family:Times;
 mso-fareast-font-family:&quot;ＭＳ 明朝&quot;;
 mso-fareast-theme-font:minor-fareast;
 mso-bidi-font-family:&quot;Times New Roman&quot;;}
.MsoChpDefault
 {mso-style-type:export-only;
 mso-default-props:yes;
 font-family:Cambria;
 mso-ascii-font-family:Cambria;
 mso-ascii-theme-font:minor-latin;
 mso-fareast-font-family:&quot;ＭＳ 明朝&quot;;
 mso-fareast-theme-font:minor-fareast;
 mso-hansi-font-family:Cambria;
 mso-hansi-theme-font:minor-latin;
 mso-bidi-font-family:&quot;Times New Roman&quot;;
 mso-bidi-theme-font:minor-bidi;
 mso-ansi-language:ES-TRAD;}
@page WordSection1
 {size:612.0pt 792.0pt;
 margin:70.85pt 3.0cm 70.85pt 3.0cm;
 mso-header-margin:36.0pt;
 mso-footer-margin:36.0pt;
 mso-paper-source:0;}
div.WordSection1
 {page:WordSection1;}
 /* List Definitions */
@list l0
 {mso-list-id:323554374;
 mso-list-type:hybrid;
 mso-list-template-ids:-122381648 -904889630 -1402429660 -1291424972 345683860 1472643148 -1379078154 1120958628 -1759581288 -340081004;}
@list l0:level1
 {mso-level-number-format:bullet;
 mso-level-text:-;
 mso-level-tab-stop:36.0pt;
 mso-level-number-position:left;
 text-indent:-18.0pt;
 font-family:Times;}
@list l0:level2
 {mso-level-start-at:0;
 mso-level-number-format:bullet;
 mso-level-text:-;
 mso-level-tab-stop:72.0pt;
 mso-level-number-position:left;
 text-indent:-18.0pt;
 font-family:Times;}
@list l0:level3
 {mso-level-number-format:bullet;
 mso-level-text:-;
 mso-level-tab-stop:108.0pt;
 mso-level-number-position:left;
 text-indent:-18.0pt;
 font-family:Times;}
@list l0:level4
 {mso-level-number-format:bullet;
 mso-level-text:-;
 mso-level-tab-stop:144.0pt;
 mso-level-number-position:left;
 text-indent:-18.0pt;
 font-family:Times;}
@list l0:level5
 {mso-level-number-format:bullet;
 mso-level-text:-;
 mso-level-tab-stop:180.0pt;
 mso-level-number-position:left;
 text-indent:-18.0pt;
 font-family:Times;}
@list l0:level6
 {mso-level-number-format:bullet;
 mso-level-text:-;
 mso-level-tab-stop:216.0pt;
 mso-level-number-position:left;
 text-indent:-18.0pt;
 font-family:Times;}
@list l0:level7
 {mso-level-number-format:bullet;
 mso-level-text:-;
 mso-level-tab-stop:252.0pt;
 mso-level-number-position:left;
 text-indent:-18.0pt;
 font-family:Times;}
@list l0:level8
 {mso-level-number-format:bullet;
 mso-level-text:-;
 mso-level-tab-stop:288.0pt;
 mso-level-number-position:left;
 text-indent:-18.0pt;
 font-family:Times;}
@list l0:level9
 {mso-level-number-format:bullet;
 mso-level-text:-;
 mso-level-tab-stop:324.0pt;
 mso-level-number-position:left;
 text-indent:-18.0pt;
 font-family:Times;}

--&gt;
&lt;/style&gt;&lt;/div&gt;
&lt;div style=&quot;line-height: 150%; text-align: justify; text-indent: 0cm;&quot;&gt;
&lt;!--[if !supportLists]--&gt;&lt;span style=&quot;font-size: 12.0pt; line-height: 150%; mso-bidi-font-family: Times; mso-fareast-font-family: Times;&quot;&gt;-&lt;span style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 7pt; font-stretch: normal; line-height: normal;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/span&gt;&lt;/span&gt;&lt;!--[endif]--&gt;&lt;span style=&quot;font-family: Cambria; font-size: 12pt; line-height: 24px;&quot;&gt;Collard, H. R., Ryerson, C. J., Corte, T. J., Jenkins, G., Kondoh, Y., Lederer, D. J., et al. (2016). Acute exacerbation of idiopathic pulmonary fibrosis an international working group report.&amp;nbsp;&lt;i&gt;American Journal of Respiratory and Critical Care Medicine&lt;/i&gt;,&amp;nbsp;&lt;i&gt;194&lt;/i&gt;(3), 265–275. http://doi.org/10.1164/rccm.201604-0801CI&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/div&gt;
</content><link rel='replies' type='application/atom+xml' href='http://blogrespira.blogspot.com/feeds/2979405121799326688/comments/default' title='Enviar comentarios'/><link rel='replies' type='text/html' href='http://blogrespira.blogspot.com/2018/08/exacerbacion-de-la-fpi.html#comment-form' title='0 comentarios'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/950616212044414228/posts/default/2979405121799326688'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/950616212044414228/posts/default/2979405121799326688'/><link rel='alternate' type='text/html' href='http://blogrespira.blogspot.com/2018/08/exacerbacion-de-la-fpi.html' title='EXACERBACIÓN DE LA FPI'/><author><name>Raúl</name><uri>http://www.blogger.com/profile/14709690265626598608</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-950616212044414228.post-4576508260502969997</id><published>2012-09-21T07:22:00.001-07:00</published><updated>2012-09-21T07:24:34.828-07:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="EPID"/><category scheme="http://www.blogger.com/atom/ns#" term="FPI"/><category scheme="http://www.blogger.com/atom/ns#" term="intersticial"/><title type='text'>FIBROSIS PULMONAR IDIOPÁTICA (FPI)</title><content type='html'>&lt;br /&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; class=&quot;tr-caption-container&quot; style=&quot;float: left; text-align: left;&quot;&gt;&lt;tbody&gt;
&lt;tr&gt;&lt;td style=&quot;text-align: center;&quot;&gt;&lt;a href=&quot;http://images.wikia.com/salud/images/e/e2/Rx_fibrosis_pulmonar.jpg&quot; imageanchor=&quot;1&quot; style=&quot;clear: left; margin-bottom: 1em; margin-left: auto; margin-right: auto;&quot;&gt;&lt;img border=&quot;0&quot; height=&quot;164&quot; src=&quot;http://images.wikia.com/salud/images/e/e2/Rx_fibrosis_pulmonar.jpg&quot; width=&quot;200&quot; /&gt;&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;tr-caption&quot; style=&quot;text-align: center;&quot;&gt;Rx tórax&lt;/td&gt;&lt;/tr&gt;
&lt;/tbody&gt;&lt;/table&gt;
Prevalencia 13/100000 en mujeres, 20/100000 en hombres.&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
Etiología desconocida. Fibrosis progresiva.&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
Es la más frec de las NII (neumopatía intersticial Idiopática), representa 50-60% de todas. Más
frecuente en varones,fumadores en la 5ª década.&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; class=&quot;tr-caption-container&quot; style=&quot;float: right; text-align: right;&quot;&gt;&lt;tbody&gt;
&lt;tr&gt;&lt;td style=&quot;text-align: center;&quot;&gt;&lt;a href=&quot;https://encrypted-tbn1.gstatic.com/images?q=tbn:ANd9GcRR9WKVDY9Jc4GQiZaBdUrUhitx75qmNxI5bSErHC8vKl5i46mo7A&quot; imageanchor=&quot;1&quot; style=&quot;clear: right; margin-bottom: 1em; margin-left: auto; margin-right: auto;&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;https://encrypted-tbn1.gstatic.com/images?q=tbn:ANd9GcRR9WKVDY9Jc4GQiZaBdUrUhitx75qmNxI5bSErHC8vKl5i46mo7A&quot; /&gt;&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;tr-caption&quot; style=&quot;text-align: center;&quot;&gt;Acropaquias&lt;/td&gt;&lt;/tr&gt;
&lt;/tbody&gt;&lt;/table&gt;
CLINICA&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
Comienzo insidioso, disnea progresiva, tos improductiva.&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
Auscultación crepitantes 90%, acropaquias 50%. Síntomas o
signos sistémicos deben hacer sospechar de diagnóstico alternativo.&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
Laboratorio: ANA o FR + en un 20%. , no hay nada específico
aunque se están investigando biomarcadores.&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
BAL. Neutrofilia discreta+/- eosinofilia&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
DIAGNÓSTICO&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;margin-left: 36pt; text-align: justify; text-indent: -18pt;&quot;&gt;
&lt;!--[if !supportLists]--&gt;A)&lt;span style=&quot;font-size: 7pt;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;
&lt;/span&gt;&lt;!--[endif]--&gt;exclusión de otras entidades clínicas definidas .&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;margin-left: 36pt; text-align: justify; text-indent: -18pt;&quot;&gt;
&lt;!--[if !supportLists]--&gt;B)&lt;span style=&quot;font-size: 7pt;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;
&lt;/span&gt;&lt;!--[endif]--&gt;NIU en la biopsia pulmonar quirúrgica, en el TCAR o ambos.&lt;/div&gt;
&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; class=&quot;tr-caption-container&quot; style=&quot;float: left; margin-right: 1em; text-align: left;&quot;&gt;&lt;tbody&gt;
&lt;tr&gt;&lt;td style=&quot;text-align: center;&quot;&gt;&lt;a href=&quot;https://encrypted-tbn1.gstatic.com/images?q=tbn:ANd9GcQxSWkXf4oGxHEMyPiBGctVpGh7CnF4UQETHVmutxWDRsy_x9z0Kg&quot; imageanchor=&quot;1&quot; style=&quot;clear: left; margin-bottom: 1em; margin-left: auto; margin-right: auto;&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;https://encrypted-tbn1.gstatic.com/images?q=tbn:ANd9GcQxSWkXf4oGxHEMyPiBGctVpGh7CnF4UQETHVmutxWDRsy_x9z0Kg&quot; /&gt;&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;tr-caption&quot; style=&quot;text-align: center;&quot;&gt;Panalización&lt;/td&gt;&lt;/tr&gt;
&lt;/tbody&gt;&lt;/table&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
Valoración multidisciplinar mejora el diagnóstico.&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
Radiología: El patrón definitorio de NIU incluye&amp;nbsp; las alteraciones reticulares de predominio
subpleural y basal con áreas de panalización, con o sin bronquiectasias de
tracción. Datos inconsistentes: predominio en campos medios o superiores,
predominio peribroncovascular, abundante vidrio deslustrado o micronódulos,quistes, mosaico,atrapamiento&amp;nbsp;aéreo, broncograma aéreo.&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
Histología: compatible y ausencia datos inconsistentes:
membranas hialinas,neumonía organizada, granulamos, inflamación alejada zonas
panalización, hallazgos sugestivos de otras patologías.&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
Diagnostico diferencial: NINE, enfermedades tejido conectivo,
asbesto, fármacos, neumopatía por hipersensibilidad, sarcoidosis avanzada.
Pacientes añosos: inhalación tóxicos, enfermedad sistémica, RGE, enfermedad
infecciosa residual, fármacos.&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
TTO?:&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
Se limita a dos fármacos: N-acetilcisteína y Pirfenidona, que todavía se están evaluando.&lt;/div&gt;
</content><link rel='replies' type='application/atom+xml' href='http://blogrespira.blogspot.com/feeds/4576508260502969997/comments/default' title='Enviar comentarios'/><link rel='replies' type='text/html' href='http://blogrespira.blogspot.com/2012/09/fibrosis-pulmonar-idiopatica-fpi.html#comment-form' title='0 comentarios'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/950616212044414228/posts/default/4576508260502969997'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/950616212044414228/posts/default/4576508260502969997'/><link rel='alternate' type='text/html' href='http://blogrespira.blogspot.com/2012/09/fibrosis-pulmonar-idiopatica-fpi.html' title='FIBROSIS PULMONAR IDIOPÁTICA (FPI)'/><author><name>Raúl</name><uri>http://www.blogger.com/profile/14709690265626598608</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-950616212044414228.post-7382276798382466048</id><published>2012-05-22T12:21:00.001-07:00</published><updated>2012-05-22T12:22:04.377-07:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="patologia"/><category scheme="http://www.blogger.com/atom/ns#" term="tos"/><title type='text'>BRONQUITIS</title><content type='html'>Es una inflamación localizada en la mucosa respiratoria de la vía aérea central , los bronquios.&amp;nbsp;Sobre todo ocurre en los meses fríos y un adulto puede tener 2-3 episodios al año.&lt;br /&gt;
&lt;br /&gt;
&lt;a href=&quot;data:image/jpeg;base64,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&quot; imageanchor=&quot;1&quot; style=&quot;clear: left; float: left; margin-bottom: 1em; margin-right: 1em;&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;data:image/jpeg;base64,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&quot; /&gt;&lt;/a&gt;SÍNTOMAS&lt;br /&gt;
Tos: se observa en el 100% de los casos, usualmente dura 2 semanas, pero en más del 25% puede durar hasta 8 semanas.&lt;br /&gt;
Producción de esputo: 90%&lt;br /&gt;
Disnea, sibilantes, roncus, dolor o picor tórax central, fiebre y malestar.&lt;br /&gt;
&lt;br /&gt;
CAUSAS&lt;br /&gt;
Infecciones respiratorias (en sólo el 55% se puede detectar el agente causal): lo más frecuente virus respiratorios : Rhinocirus , adenovirus,echovirus,virus influenza y parainfluenza, enterovirus,coronavirus, Coxsackie, virus respiratorio sincitial. Bacterias. neumococo, Haemophilus influenzae, Moxarella Catarrhalis y atípicas (Mycoplasma, Chlamydia) y Bordetella Pertussis&lt;br /&gt;
&lt;br /&gt;
PRONÓSTICO&lt;br /&gt;
La bronquitis aguda es una enfermedad autolimitada habitualmente. En algunos casos se desarrolla asma o síntomas de bronquitis crónica.&lt;br /&gt;
&lt;br /&gt;
DIAGNÓSTICO&lt;br /&gt;
Clínico. Habitualmente no hay signos de gravedad. No son necesarias pruebas de laboratorio. Se puede plantear el cultivo de esputo para guiar la antibioterapia en casos severos.&lt;br /&gt;
El diagnóstico diferencial con neumonía, asma, bronquiectasias.&lt;br /&gt;
&lt;br /&gt;
TRATAMIENTO&lt;br /&gt;
Sintomático. Dextrometorfano&amp;nbsp;reduce la tos. Si hay disnea y pitos broncodilatadores. Antibioterapia sólo se recomienda en caso de fiebre y/o comorbilidades (cefalosporinas de segunda generación, aminopenicilinas).&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;Bronquitis crónica:&lt;/b&gt; es un concepto clínico, tos productiva durante 3 meses/año en 2 años consecutivos, en un paciente que se ha descartado otras causas. El tabaquismo es el principal factor de riesgo.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;</content><link rel='replies' type='application/atom+xml' href='http://blogrespira.blogspot.com/feeds/7382276798382466048/comments/default' title='Enviar comentarios'/><link rel='replies' type='text/html' href='http://blogrespira.blogspot.com/2012/05/bronquitis.html#comment-form' title='0 comentarios'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/950616212044414228/posts/default/7382276798382466048'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/950616212044414228/posts/default/7382276798382466048'/><link rel='alternate' type='text/html' href='http://blogrespira.blogspot.com/2012/05/bronquitis.html' title='BRONQUITIS'/><author><name>Raúl</name><uri>http://www.blogger.com/profile/14709690265626598608</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-950616212044414228.post-3578515676654820165</id><published>2012-05-21T13:39:00.003-07:00</published><updated>2012-05-21T13:43:31.585-07:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="Infiltados"/><category scheme="http://www.blogger.com/atom/ns#" term="insuficiencia respiratoria"/><category scheme="http://www.blogger.com/atom/ns#" term="patologia"/><title type='text'>DAÑO PULMONAR AGUDO</title><content type='html'>El daño pulmonar agudo &amp;nbsp;es definido por el ratio PaO2/FiO2&amp;lt; ó = 300 mmHg, su manifestación más severa el síndrome de distress respiratorio agudo por un ratio &amp;lt; 200 mmHg, acompañados de infiltrados bilaterales en la radiografía. Se ha de excluir el fallo cardíaco. A las 24 horas debe persistir.&lt;br /&gt;
&lt;br /&gt;
&lt;a href=&quot;data:image/jpeg;base64,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&quot; imageanchor=&quot;1&quot; style=&quot;clear: left; float: left; margin-bottom: 1em; margin-right: 1em;&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;data:image/jpeg;base64,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&quot; /&gt;&lt;/a&gt;CAUSAS:&lt;br /&gt;
Daño pulmonar directo: neumonía, aspiración, inhalación de tóxicos, contusión, la ventilación mecánica...&lt;br /&gt;
Daño pulmonar indirecto: sepsis, pancreatitis, quemados, transfusiones masivas...&lt;br /&gt;
&lt;br /&gt;
La mortalidad del cuadro es muy alta , de un 35-40%&lt;br /&gt;
&lt;br /&gt;
FISIOPATOLOGÍA:&lt;br /&gt;
Se produce un incremento de la permeabilidad pulmonar capilar, esto produce un shunt derecha izquierda , por lo que baja la presión de oxígeno en sangre arterial.&lt;br /&gt;
Se ha divido en 3 fases:&lt;br /&gt;
1- Fase inflamatoria inicial (exudativa).&lt;br /&gt;
2- Fase fibroproliferativa&lt;br /&gt;
3- Fibrosis (fase final)&lt;br /&gt;
&lt;br /&gt;
TRATAMIENTO&lt;br /&gt;
Las medidas son evitar el daño pulmonar, identificando las causas y evitando otras (aspiraciones, barotraumas, toxicidad por oxígeno, infecciones,,,).&lt;br /&gt;
Medidas de soporte cardiovascular, balance de fluidos,nutricional...&lt;br /&gt;
Mejorar la oxigenación mediante oxigenoterapia y ventilación mecánica, intentando no producir efectos iatrogénicos : disminuir volumen Tidal (6 ml/kg) e intentando disminuir la presión pico, a pesar de una hipercapnia asociada.&lt;br /&gt;
Tratamiento farmacológico: los corticoides, a pesar de su uso, muy extendido, no han demostrado justificación para un uso tan extendido. El óxido nítrico no ha demostrado efectividad.</content><link rel='replies' type='application/atom+xml' href='http://blogrespira.blogspot.com/feeds/3578515676654820165/comments/default' title='Enviar comentarios'/><link rel='replies' type='text/html' href='http://blogrespira.blogspot.com/2012/05/dano-pulmonar.html#comment-form' title='0 comentarios'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/950616212044414228/posts/default/3578515676654820165'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/950616212044414228/posts/default/3578515676654820165'/><link rel='alternate' type='text/html' href='http://blogrespira.blogspot.com/2012/05/dano-pulmonar.html' title='DAÑO PULMONAR AGUDO'/><author><name>Raúl</name><uri>http://www.blogger.com/profile/14709690265626598608</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-950616212044414228.post-4564023242182190265</id><published>2012-05-15T08:17:00.003-07:00</published><updated>2012-05-15T08:22:18.815-07:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="tecnicas"/><category scheme="http://www.blogger.com/atom/ns#" term="web 2.0. internet"/><title type='text'>WEB 2.0 Y MEDICINA: TWITTER</title><content type='html'>&lt;div class=&quot;MsoNormal&quot; style=&quot;border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0cm 0cm 0pt;&quot;&gt;
Microblogging&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;margin: 0cm 0cm 0pt;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;margin: 0cm 0cm 0pt;&quot;&gt;
Permite enviar mensajes de 140 caracteres. Exige capacidad de síntesis,. Las posibilidades son el intercambio de opiniones, promoción, compartir aficiones, enlaces...&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0cm 0cm 0pt;&quot;&gt;
&lt;a href=&quot;http://www.google.es/imgres?imgurl=http://scharrenberg.net/wp-content/uploads/2011/06/seguidores.jpg&amp;amp;imgrefurl=http://scharrenberg.net/2011/06/limite-2000-usuarios-twitter/&amp;amp;usg=__MebQho5Yzd9qL23NPtv2onAYjEo=&amp;amp;h=371&amp;amp;w=500&amp;amp;sz=22&amp;amp;hl=es&amp;amp;start=4&amp;amp;sig2=qSTX3eOaeeLwHqMHqoescA&amp;amp;zoom=1&amp;amp;tbnid=dvO1okGLblLtiM:&amp;amp;tbnh=96&amp;amp;tbnw=130&amp;amp;ei=UnOyT461HcjA0QXa-4WuCQ&amp;amp;prev=/search%3Fq%3Dtwitter%26um%3D1%26hl%3Des%26sa%3DN%26tbm%3Disch&amp;amp;um=1&amp;amp;itbs=1&quot; style=&quot;clear: left; cssfloat: left; float: left; margin-bottom: 1em; margin-right: 1em;&quot;&gt;&lt;img height=&quot;236px&quot; src=&quot;http://t1.gstatic.com/images?q=tbn:ANd9GcQu2XeiK-kCn5eGOf6NMORUfpCIqBGAd1Eylryb8PMPQhAxL-UKtdBsQqyE&quot; width=&quot;320px&quot; /&gt;&lt;/a&gt;Permite enviar mensajes al público en general, a una red o a una persona.&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0cm 0cm 0pt;&quot;&gt;
En está plataforma puedes seguir a personas o instituciones de interés, puedes compartir información con tus propios seguidores, generando la información o Retwitteandola de la gente a la que sigues. Las personas o entidades concretas van precedidas de @ y los temas por&lt;span style=&quot;mso-spacerun: yes;&quot;&gt;&amp;nbsp; &lt;/span&gt;# ( a estos términos precedidos por la # se llaman Hashtag y&amp;nbsp;pueden ser buscados con el motor de búsqueda). Los Hashtags son importantes porque sirven para determinar los “trending topics” o temas más buscados.&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0cm 0cm 0pt;&quot;&gt;
Se pueden seguir y promover temas de todos los tipos, incluso sanitarios.&lt;br /&gt;
&lt;br /&gt;
Me podéis seguir en twitter en @godoy_raul&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://blogrespira.blogspot.com/feeds/4564023242182190265/comments/default' title='Enviar comentarios'/><link rel='replies' type='text/html' href='http://blogrespira.blogspot.com/2012/05/web-20-y-medicina-twitter.html#comment-form' title='0 comentarios'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/950616212044414228/posts/default/4564023242182190265'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/950616212044414228/posts/default/4564023242182190265'/><link rel='alternate' type='text/html' href='http://blogrespira.blogspot.com/2012/05/web-20-y-medicina-twitter.html' title='WEB 2.0 Y MEDICINA: TWITTER'/><author><name>Raúl</name><uri>http://www.blogger.com/profile/14709690265626598608</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-950616212044414228.post-6175289167379563425</id><published>2012-05-14T07:50:00.001-07:00</published><updated>2012-05-14T07:52:16.821-07:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="signos"/><category scheme="http://www.blogger.com/atom/ns#" term="síntomas"/><category scheme="http://www.blogger.com/atom/ns#" term="tos"/><title type='text'>TOS CRÓNICA: DIAGNÓSTICO</title><content type='html'>&lt;br /&gt;
&lt;div class=&quot;MsoNormal&quot;&gt;
&lt;b&gt;DIAGNÓSTICO&lt;/b&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; class=&quot;tr-caption-container&quot; style=&quot;float: left; margin-right: 1em; text-align: left;&quot;&gt;&lt;tbody&gt;
&lt;tr&gt;&lt;td style=&quot;text-align: center;&quot;&gt;&lt;a href=&quot;http://www.archbronconeumol.org/ficheros/images/6/6v38n05/grande/6v38n05-13031936tab05.gif&quot; imageanchor=&quot;1&quot; style=&quot;clear: left; margin-bottom: 1em; margin-left: auto; margin-right: auto;&quot;&gt;&lt;img border=&quot;0&quot; height=&quot;400&quot; src=&quot;http://www.archbronconeumol.org/ficheros/images/6/6v38n05/grande/6v38n05-13031936tab05.gif&quot; width=&quot;396&quot; /&gt;&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;tr-caption&quot; style=&quot;text-align: center;&quot;&gt;Extraido de Archivos de Bronconeumología.&lt;/td&gt;&lt;/tr&gt;
&lt;/tbody&gt;&lt;/table&gt;
&lt;div class=&quot;MsoNormal&quot;&gt;
Diversos estudios han demostrado que la frecuencia,
intensidad, temporalidad, expectoración, relación con comidas no guardan
relación con la causa.&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot;&gt;
Se debe hacer atendiendo a la frecuencia etiológica y a los
recursos diagnósticos, así se puede realizar en diferentes fases:&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot;&gt;
&lt;b&gt;FASE I&lt;/b&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot;&gt;
Anamnesis: Características de la tos, síntomas que puedan
orientar hacia otras enfermedades: pirosis, regurgitación, rinorrea,
sibilancias, disnea, antecedentes psicológicos. La existencia de hábito tabáquico
y fármacos (IECAS y Betabloqueantes).&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot;&gt;
Si no hay diagnóstico después de la anamnesis retirar tabaco
y fármacos y esperar&amp;nbsp; 4 semanas, realizar&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot;&gt;
- &lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;margin-left: 36.0pt; mso-list: l3 level1 lfo2; tab-stops: list 36.0pt; text-indent: -18.0pt;&quot;&gt;
-&lt;span style=&quot;font-size: 7pt;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;
&lt;/span&gt;Radiografía tórax y de senos paranasales.&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;margin-left: 36.0pt; mso-list: l3 level1 lfo2; tab-stops: list 36.0pt; text-indent: -18.0pt;&quot;&gt;
-&lt;span style=&quot;font-size: 7pt;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;
&lt;/span&gt;Espirometría y prueba broncodilatadora&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;margin-left: 18.0pt;&quot;&gt;
Si se llega al diagnóstico se
pone el tratamiento adecuado. Si no se llega al diagnóstico o con el
tratamiento no mejora vamos a la fase II&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot;&gt;
&lt;b&gt;FASE II&lt;/b&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;margin-left: 36.0pt; mso-list: l1 level1 lfo3; tab-stops: list 36.0pt; text-indent: -18.0pt;&quot;&gt;
1-&lt;span style=&quot;font-size: 7pt;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;
&lt;/span&gt;Valoración otorrinolaringológica especializada, con TAC
craneal si debemos descartar sinusitis.&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;margin-left: 36.0pt; mso-list: l1 level1 lfo3; tab-stops: list 36.0pt; text-indent: -18.0pt;&quot;&gt;
2-&lt;span style=&quot;font-size: 7pt;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;
&lt;/span&gt;Test de broncoprovocación (metacolina, histamina...). Esputos
para ver eosinófilos. Con estas pruebas se verá si hay asma o bronquitis
eosinofílica.&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;margin-left: 36.0pt; mso-list: l1 level1 lfo3; tab-stops: list 36.0pt; text-indent: -18.0pt;&quot;&gt;
3-&lt;span style=&quot;font-size: 7pt;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;
&lt;/span&gt;pHmetría esofágica.&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot;&gt;
Si no hay diagnóstico pasa a fase III&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot;&gt;
&lt;b&gt;FASE III&lt;/b&gt; : Causas infrecuentes:&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;margin-left: 36.0pt; mso-list: l2 level1 lfo4; tab-stops: list 36.0pt; text-indent: -18.0pt;&quot;&gt;
1-&lt;span style=&quot;font-size: 7pt;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;
&lt;/span&gt;TAC torácica y fibrobroncoscopia: descarta neumopatías
intersticiales , malformaciones, cuerpos extraños, tumores...&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;margin-left: 36.0pt; mso-list: l2 level1 lfo4; tab-stops: list 36.0pt; text-indent: -18.0pt;&quot;&gt;
2-&lt;span style=&quot;font-size: 7pt;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;
&lt;/span&gt;Si , a pesar , de todo no hay diagnóstico considerar la tos
psicógena.&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;margin-left: 36.0pt; mso-list: l2 level1 lfo4; tab-stops: list 36.0pt; text-indent: -18.0pt;&quot;&gt;
&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://blogrespira.blogspot.com/feeds/6175289167379563425/comments/default' title='Enviar comentarios'/><link rel='replies' type='text/html' href='http://blogrespira.blogspot.com/2012/05/tos-cronica-ii.html#comment-form' title='0 comentarios'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/950616212044414228/posts/default/6175289167379563425'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/950616212044414228/posts/default/6175289167379563425'/><link rel='alternate' type='text/html' href='http://blogrespira.blogspot.com/2012/05/tos-cronica-ii.html' title='TOS CRÓNICA: DIAGNÓSTICO'/><author><name>Raúl</name><uri>http://www.blogger.com/profile/14709690265626598608</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-950616212044414228.post-4502563666153373898</id><published>2012-05-11T04:06:00.002-07:00</published><updated>2012-05-11T04:06:35.646-07:00</updated><title type='text'>TOS CRÓNICA: DEFINICIÓN, CAUSAS</title><content type='html'>&lt;div class=&quot;MsoNormal&quot; style=&quot;margin: 0cm 0cm 0pt;&quot;&gt;
Es un reflejo, en ocasiones voluntario, cuya finalidad es expulsar secreciones u otros materiales de las vías aéreas.&lt;span style=&quot;mso-spacerun: yes;&quot;&gt;&amp;nbsp; &lt;/span&gt;Hay que coordinar la inspiración, el cierre de la glotis, la espiración y apertura brusca&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;margin: 0cm 0cm 0pt;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0cm 0cm 0pt;&quot;&gt;
&lt;a href=&quot;http://alimentosparacurar.com/!sitios/!AlimentosParaCurar/ilustraciones/tos_remedios.jpg&quot; id=&quot;thumbnail&quot; style=&quot;clear: left; cssfloat: left; float: left; margin-bottom: 1em; margin-right: 1em;&quot;&gt;&lt;img alt=&quot;Ver imagen en tamaño completo&quot; height=&quot;132px&quot; src=&quot;http://t2.gstatic.com/images?q=tbn:ANd9GcTGkcncApTp-r21-g1nAvzkNhuUpP0fIhdqBvHEB20qPCz1WYwN3VZu9w&quot; style=&quot;border-bottom: 1px solid; border-left: 1px solid; border-right: 1px solid; border-top: 1px solid; float: left; margin: 10px 10px 0px;&quot; width=&quot;200px&quot; /&gt;&lt;/a&gt;Ocasiona entre el 10-20 % de visitas médicas. Y tercera causa de consulta a especializada.&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0cm 0cm 0pt;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0cm 0cm 0pt;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0cm 0cm 0pt;&quot;&gt;
Crónica es cuando persiste más de 3 semanas y no está relacionada con un proceso agudo.&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0cm 0cm 0pt;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;margin: 0cm 0cm 0pt;&quot;&gt;
CAUSAS:&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;margin: 0cm 0cm 0pt;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;margin: 0cm 0cm 0pt;&quot;&gt;
Las tres causas más frecuentes, y primeras a descartar, son: El reflujo gastroesofágico, el asma y el goteo postnasal. Aunque , por supuesto, hay que tener en cuenta el tabaco, los fármacos ( IECAS; betabolqueantes,..) enfermedades como la EPOC. También es frecuente, según las series, la bronquitis eosinofílica. Otras son: tumores, enfermedades intersticiales pulmonares, tos postinfecciosa (que puede durar mas de&lt;span style=&quot;mso-spacerun: yes;&quot;&gt;&amp;nbsp; &lt;/span&gt;8 semanas) y la causa psicológica. Hay un sin número de otras posibles causas menos frecuentes, entre las que se incluyen las de etiología otorrinolaringológica (pólipos nasales, alteraciones faringe, laringe, conducto auditivo...), arteritis temporal, inhalación objetos....&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;margin: 0cm 0cm 0pt;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;margin: 0cm 0cm 0pt;&quot;&gt;
En un porcentaje elevado de los casos hay relacionadas dos o más causas en el proceso.&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://blogrespira.blogspot.com/feeds/4502563666153373898/comments/default' title='Enviar comentarios'/><link rel='replies' type='text/html' href='http://blogrespira.blogspot.com/2012/05/tos-cronica-definicion-causas.html#comment-form' title='0 comentarios'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/950616212044414228/posts/default/4502563666153373898'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/950616212044414228/posts/default/4502563666153373898'/><link rel='alternate' type='text/html' href='http://blogrespira.blogspot.com/2012/05/tos-cronica-definicion-causas.html' title='TOS CRÓNICA: DEFINICIÓN, CAUSAS'/><author><name>Raúl</name><uri>http://www.blogger.com/profile/14709690265626598608</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-950616212044414228.post-5278573069586596929</id><published>2012-05-08T09:12:00.002-07:00</published><updated>2012-05-08T09:21:32.290-07:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="hipersomnolencia"/><category scheme="http://www.blogger.com/atom/ns#" term="poligrafía"/><category scheme="http://www.blogger.com/atom/ns#" term="sueño"/><title type='text'>Síndrome de piernas inquietas II</title><content type='html'>&lt;div class=&quot;MsoNormal&quot; style=&quot;margin: 0cm 0cm 0pt;&quot;&gt;
&lt;strong&gt;FISIOPATOLOGÍA&lt;/strong&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;margin: 0cm 0cm 0pt;&quot;&gt;
Deriva de una disfunción de sistema nervioso central&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;margin: 0cm 0cm 0pt;&quot;&gt;
Tirosina se convierte por la Tirosina hidoxilasa (cofactor Hierro)en DOPAy ésta por la DOPA decarboxilasa en Dopamina.&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;margin: 0cm 0cm 0pt;&quot;&gt;
Al utilizar el hierro todo lo que suponga una disminución de éste en sistema nervioso central produce una disminución de dopamina y&lt;span style=&quot;mso-spacerun: yes;&quot;&gt;&amp;nbsp; &lt;/span&gt;la sintomatología.&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;margin: 0cm 0cm 0pt;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;margin: 0cm 0cm 0pt;&quot;&gt;
&lt;strong&gt;CRITERIOS CLÍNICOS&lt;/strong&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;margin: 0cm 0cm 0pt;&quot;&gt;
Mayores:&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;margin: 0cm 0cm 0pt 36pt; mso-list: l1 level1 lfo1; tab-stops: list 36.0pt; text-indent: -18pt;&quot;&gt;
-&lt;span style=&quot;font-family: &#39;Times New Roman&#39;;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;Sensación desagradable que provoca necesidad de mover las piernas.&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;margin: 0cm 0cm 0pt 36pt; mso-list: l1 level1 lfo1; tab-stops: list 36.0pt; text-indent: -18pt;&quot;&gt;
-&lt;span style=&quot;font-family: &#39;Times New Roman&#39;;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;Empeora con el reposo&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;margin: 0cm 0cm 0pt 36pt; mso-list: l1 level1 lfo1; tab-stops: list 36.0pt; text-indent: -18pt;&quot;&gt;
-&lt;span style=&quot;font-family: &#39;Times New Roman&#39;;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;Mejora con el movimiento&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;margin: 0cm 0cm 0pt 36pt; mso-list: l1 level1 lfo1; tab-stops: list 36.0pt; text-indent: -18pt;&quot;&gt;
-&lt;span style=&quot;font-family: &#39;Times New Roman&#39;;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;Ritmo circadiano: empeora por la noche&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;margin: 0cm 0cm 0pt;&quot;&gt;
Menores:&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;margin: 0cm 0cm 0pt 36pt; mso-list: l1 level1 lfo1; tab-stops: list 36.0pt; text-indent: -18pt;&quot;&gt;
-&lt;span style=&quot;font-family: &#39;Times New Roman&#39;;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;Antecedentes familiares&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;margin: 0cm 0cm 0pt 36pt; mso-list: l1 level1 lfo1; tab-stops: list 36.0pt; text-indent: -18pt;&quot;&gt;
-&lt;span style=&quot;font-family: &#39;Times New Roman&#39;;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;Respuesta a dopaminérgicos.&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;margin: 0cm 0cm 0pt 36pt; mso-list: l1 level1 lfo1; tab-stops: list 36.0pt; text-indent: -18pt;&quot;&gt;
-&lt;span style=&quot;font-family: &#39;Times New Roman&#39;;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;Movimientos periódicos de miembros en reposo o vigilia&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;margin: 0cm 0cm 0pt 36pt; mso-list: l1 level1 lfo1; tab-stops: list 36.0pt; text-indent: -18pt;&quot;&gt;
-&lt;span style=&quot;font-family: &#39;Times New Roman&#39;;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;Alteración del sueño&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;margin: 0cm 0cm 0pt 36pt; mso-list: l1 level1 lfo1; tab-stops: list 36.0pt; text-indent: -18pt;&quot;&gt;
-&lt;span style=&quot;font-family: &#39;Times New Roman&#39;;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;Curso progresivo pero con oscilaciones&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;margin: 0cm 0cm 0pt;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;margin: 0cm 0cm 0pt;&quot;&gt;
Las consecuencias de la alteración del sueño son cefalea, ansiedad, cansancio, irritabilidad, depresión. Puede haber relación con la hipertensión. Los síntomas se localizan en ambas piernas, en ocasiones afecta a los brazos, raramente a otras partes. La enfermedad tiene un curso progresivo&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;margin: 0cm 0cm 0pt 18pt;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;margin: 0cm 0cm 0pt;&quot;&gt;
&lt;strong&gt;DIAGNÓSTICO&lt;/strong&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;margin: 0cm 0cm 0pt;&quot;&gt;
Los cuatro criterios mayores.&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;margin: 0cm 0cm 0pt;&quot;&gt;
Procedimientos de apoyo: Polisomnografía completa ( nos permite detectar los movimientos periódicos que son de flexión dorsal del pie), test de inmovilización forzada, prueba con fármacos dopaminérgicos con levodopa. &lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;margin: 0cm 0cm 0pt;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;margin: 0cm 0cm 0pt;&quot;&gt;
&lt;strong&gt;DIAGNÓSTICO DIFERENCIAL&lt;/strong&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;margin: 0cm 0cm 0pt 36pt; mso-list: l0 level1 lfo2; tab-stops: list 36.0pt; text-indent: -18pt;&quot;&gt;
1-&lt;span style=&quot;font-family: &#39;Times New Roman&#39;;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;Disconfort posicional.&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;margin: 0cm 0cm 0pt 36pt; mso-list: l0 level1 lfo2; tab-stops: list 36.0pt; text-indent: -18pt;&quot;&gt;
2-&lt;span style=&quot;font-family: &#39;Times New Roman&#39;;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;La acatisia, inquietud motora que obliga a moverse.&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;margin: 0cm 0cm 0pt 36pt; mso-list: l0 level1 lfo2; tab-stops: list 36.0pt; text-indent: -18pt;&quot;&gt;
3-&lt;span style=&quot;font-family: &#39;Times New Roman&#39;;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;Mioclonus hípnico o del inicio del sueño&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;margin: 0cm 0cm 0pt 36pt; mso-list: l0 level1 lfo2; tab-stops: list 36.0pt; text-indent: -18pt;&quot;&gt;
4-&lt;span style=&quot;font-family: &#39;Times New Roman&#39;;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;Transtorno de consucta en sueño REM&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;margin: 0cm 0cm 0pt 36pt; mso-list: l0 level1 lfo2; tab-stops: list 36.0pt; text-indent: -18pt;&quot;&gt;
5-&lt;span style=&quot;font-family: &#39;Times New Roman&#39;;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;Calambres musculares&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;margin: 0cm 0cm 0pt 36pt; mso-list: l0 level1 lfo2; tab-stops: list 36.0pt; text-indent: -18pt;&quot;&gt;
6-&lt;span style=&quot;font-family: &#39;Times New Roman&#39;;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;Polineuropatías&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;margin: 0cm 0cm 0pt 36pt; mso-list: l0 level1 lfo2; tab-stops: list 36.0pt; text-indent: -18pt;&quot;&gt;
7-&lt;span style=&quot;font-family: &#39;Times New Roman&#39;;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;Insuficiencia venosa de miembros inferiores&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;margin: 0cm 0cm 0pt 36pt; mso-list: l0 level1 lfo2; tab-stops: list 36.0pt; text-indent: -18pt;&quot;&gt;
8-&lt;span style=&quot;font-family: &#39;Times New Roman&#39;;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;Pueden asociarse a otras patologías del sueño: narcolepsia, síndrome de apneas obstructiva&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;margin: 0cm 0cm 0pt 36pt; mso-list: l0 level1 lfo2; tab-stops: list 36.0pt; text-indent: -18pt;&quot;&gt;
9-&lt;span style=&quot;font-family: &#39;Times New Roman&#39;;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;Fármacos: antidopaminérgicos (neurolépticos, benzaminas (metoclopramida, sulpirida...), antidepresivos, litio, antihistamínicos...&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;margin: 0cm 0cm 0pt 36pt; mso-list: l0 level1 lfo2; tab-stops: list 36.0pt; text-indent: -18pt;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;margin: 0cm 0cm 0pt 36pt; mso-list: l0 level1 lfo2; tab-stops: list 36.0pt; text-indent: -18pt;&quot;&gt;
Más información en &lt;a href=&quot;http://blogrespira.blogspot.com.es/2012/05/sindrome-de-piernas-inquietas.html&quot; target=&quot;_blank&quot;&gt;síndrome de piernas inquiétas parte I&lt;/a&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;margin: 0cm 0cm 0pt;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;strong&gt;&lt;/strong&gt;</content><link rel='replies' type='application/atom+xml' href='http://blogrespira.blogspot.com/feeds/5278573069586596929/comments/default' title='Enviar comentarios'/><link rel='replies' type='text/html' href='http://blogrespira.blogspot.com/2012/05/sindrome-de-piernas-inquietas-ii.html#comment-form' title='0 comentarios'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/950616212044414228/posts/default/5278573069586596929'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/950616212044414228/posts/default/5278573069586596929'/><link rel='alternate' type='text/html' href='http://blogrespira.blogspot.com/2012/05/sindrome-de-piernas-inquietas-ii.html' title='Síndrome de piernas inquietas II'/><author><name>Raúl</name><uri>http://www.blogger.com/profile/14709690265626598608</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-950616212044414228.post-6288735852200169608</id><published>2012-05-07T12:32:00.001-07:00</published><updated>2012-05-08T09:20:25.263-07:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="hipersomnolencia"/><category scheme="http://www.blogger.com/atom/ns#" term="sueño"/><title type='text'>Síndrome de piernas inquietas</title><content type='html'>&lt;br /&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
Lo describió Thomas Willis en el siglo XVII. Ekbom en 1945 acuñó el término por el que se le conoce. A finales de los 80 se le incluyó como uno de los desordenes del sueño.&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;a href=&quot;https://encrypted-tbn0.google.com/images?q=tbn:ANd9GcR3w8AhnOxgHXvIb02h_0mZErGLHf1RlcvlupIQgUfrtiaubkwvLA&quot; imageanchor=&quot;1&quot; style=&quot;clear: left; float: left; margin-bottom: 1em; margin-right: 1em;&quot;&gt;&lt;img border=&quot;0&quot; height=&quot;237px&quot; src=&quot;https://encrypted-tbn0.google.com/images?q=tbn:ANd9GcR3w8AhnOxgHXvIb02h_0mZErGLHf1RlcvlupIQgUfrtiaubkwvLA&quot; width=&quot;320px&quot; /&gt;&lt;/a&gt;Es un síndrome sensitivo-motor que cursa con sensación&amp;nbsp; molesta en las piernas, que obliga a moverlas, empeora con el reposo y al final del día (tiene un ritmo circadíano), se alivia con el movimiento (tiene que cumplir todas las características para el diagnóstico). Puede haber antecedentes familiares, movimientos periódicos en vigilia o&amp;nbsp; en el sueño, y respuesta a fármacos dopaminérgicos.&lt;/div&gt;
&lt;div class=&quot;MsoBodyText&quot;&gt;
&lt;div style=&quot;text-align: justify;&quot;&gt;
La prevalencia está entre el 1 y el 5 %. Es más frecuente en mujeres y en la raza caucásica y en edades avanzadas. En los niños se confunde con el síndrome de hiperactividad.&lt;/div&gt;
&lt;/div&gt;
&lt;div class=&quot;MsoBodyText&quot;&gt;
&lt;div style=&quot;text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;div class=&quot;MsoBodyText&quot;&gt;
&lt;span style=&quot;text-align: justify;&quot;&gt;Es una enfermedad muy infradiagnosticada.&lt;/span&gt; &lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;b&gt;&lt;br /&gt;&lt;/b&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;b&gt;Etiología&lt;/b&gt;.&lt;br /&gt;
-Formas idiopáticas con mayor componente genético y edad de inicio más temprana. Es más frecuente.&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
-Secundarias&lt;br /&gt;
&amp;nbsp;Factores que desencadenan o empeoran: ferropenia, embarazo (sobre todo en el tercer trimestre), insuficiencia renal crónica, antidopaminérgicos.&lt;br /&gt;
&lt;div style=&quot;text-align: left;&quot;&gt;
&amp;nbsp; Enfermedades que pueden dar una clínica parecida: Polineuropatías(diabetes), mielopatías, artritis reumatoide, fibromialgia...&lt;br /&gt;
&lt;br /&gt;
Sigue: &lt;a href=&quot;http://blogrespira.blogspot.com.es/2012/05/sindrome-de-piernas-inquietas-ii.html&quot; target=&quot;_blank&quot;&gt;Síndrome de piernas inquietas II&lt;/a&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://blogrespira.blogspot.com/feeds/6288735852200169608/comments/default' title='Enviar comentarios'/><link rel='replies' type='text/html' href='http://blogrespira.blogspot.com/2012/05/sindrome-de-piernas-inquietas.html#comment-form' title='0 comentarios'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/950616212044414228/posts/default/6288735852200169608'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/950616212044414228/posts/default/6288735852200169608'/><link rel='alternate' type='text/html' href='http://blogrespira.blogspot.com/2012/05/sindrome-de-piernas-inquietas.html' title='Síndrome de piernas inquietas'/><author><name>Raúl</name><uri>http://www.blogger.com/profile/14709690265626598608</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-950616212044414228.post-9180562223412126118</id><published>2012-04-24T09:20:00.000-07:00</published><updated>2012-05-15T08:21:31.496-07:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="web 2.0. internet"/><title type='text'>WEB 2.0 y Medicina II: Herramientas</title><content type='html'>&lt;div style=&quot;text-align: left;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot;&gt;
&lt;div style=&quot;text-align: justify;&quot;&gt;
&lt;div style=&quot;text-align: left;&quot;&gt;
&amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp;&lt;b&gt; BLOG&lt;/b&gt;:&lt;/div&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot;&gt;
&lt;div style=&quot;text-align: justify;&quot;&gt;
&lt;div style=&quot;text-align: left;&quot;&gt;
&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; Es una especie de página web en la que el autor publica por orden cronológico ciertas entradas. Son fuentes de información y actualización&lt;/div&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;https://encrypted-tbn3.google.com/images?q=tbn:ANd9GcR3-OazRZlUTXQHDhHzMif3FH_gwLgkwCrgkeqH5WYkdamgrUX6Hw&quot; imageanchor=&quot;1&quot; style=&quot;clear: left; float: left; margin-bottom: 1em; margin-right: 1em; text-align: left;&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;https://encrypted-tbn3.google.com/images?q=tbn:ANd9GcR3-OazRZlUTXQHDhHzMif3FH_gwLgkwCrgkeqH5WYkdamgrUX6Hw&quot; /&gt;&lt;/a&gt;&lt;br /&gt;
&lt;div style=&quot;text-align: justify;&quot;&gt;
&lt;div style=&quot;text-align: left;&quot;&gt;
&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;b&gt; &lt;a href=&quot;http://blogrespira.blogspot.com.es/2012/05/web-20-y-medicina-twitter.html&quot; target=&quot;_blank&quot;&gt;TWITTER&lt;/a&gt;&lt;/b&gt;:&lt;/div&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot;&gt;
&lt;div style=&quot;text-align: justify;&quot;&gt;
&lt;div style=&quot;text-align: left;&quot;&gt;
&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; Es una red social donde se publican mensajes de 140 caracteres como mucho. Se puede seguir a otros usuarios, y otros usuarios pueden seguirte. Se pueden buscar temas de interés y personas o instituciones con opiniones que te interesen.&lt;/div&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot;&gt;
&lt;div style=&quot;text-align: justify;&quot;&gt;
&lt;div style=&quot;text-align: left;&quot;&gt;
&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;b&gt;FACEBOOK&lt;/b&gt;:&lt;/div&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot;&gt;
&lt;div style=&quot;text-align: justify;&quot;&gt;
&lt;div style=&quot;text-align: left;&quot;&gt;
&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; Red social que permite relaciones de tipo interpersonal, por grupos, e incluso páginas a las que puedes seguir, propias o de instituciones o grupos.&lt;/div&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot;&gt;
&lt;div style=&quot;text-align: justify;&quot;&gt;
&lt;div style=&quot;text-align: left;&quot;&gt;
&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;b&gt;LINKED-IN:&lt;/b&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot;&gt;
&lt;div style=&quot;text-align: justify;&quot;&gt;
&lt;div style=&quot;text-align: left;&quot;&gt;
&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; Red social para contactos entre profesionales. También se pueden hacer grupos, puedes colgar currículum...&lt;/div&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot;&gt;
&lt;div style=&quot;text-align: justify;&quot;&gt;
&lt;div style=&quot;text-align: left;&quot;&gt;
&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;b&gt; YOUTUBE:&lt;/b&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot;&gt;
&lt;div style=&quot;text-align: justify;&quot;&gt;
&lt;div style=&quot;text-align: left;&quot;&gt;
&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; Web para compartir vídeos. Se puede crear cuentas para recibir los vídeos de tus intereses, se pueden hacer búsquedas y puedes subir tus propios vídeos.&lt;/div&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot;&gt;
&lt;div style=&quot;text-align: justify;&quot;&gt;
&lt;div style=&quot;text-align: left;&quot;&gt;
&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;b&gt;FLICKR:&lt;/b&gt;&lt;/div&gt;
&lt;div style=&quot;text-align: left;&quot;&gt;
&amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; Permite almacenar,ordenar,buscar,compartir fotografías, vídeos, presentaciones&lt;/div&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot;&gt;
&lt;div style=&quot;text-align: justify;&quot;&gt;
&lt;div style=&quot;text-align: left;&quot;&gt;
&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;b&gt; Fuentes RSS:&lt;/b&gt;&lt;/div&gt;
&lt;div style=&quot;text-align: left;&quot;&gt;
&amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; Son fuentes para noticias que se siguen mediante agregadores, es importante nombrar el de Google.&lt;/div&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot;&gt;
&lt;div style=&quot;text-align: justify;&quot;&gt;
&lt;div style=&quot;text-align: left;&quot;&gt;
&amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp;&amp;nbsp;&lt;b&gt;WIKIS:&lt;/b&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify;&quot;&gt;
&lt;div style=&quot;text-align: left;&quot;&gt;
&amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp;Páginas web que pueden ser editadas por múltiples usuarios para crear, modificar, aumentar una información que se comparte.&lt;/div&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify;&quot;&gt;
&lt;div style=&quot;text-align: left;&quot;&gt;
&amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &lt;b&gt;GOOGLE:&lt;/b&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify;&quot;&gt;
&lt;div style=&quot;text-align: left;&quot;&gt;
&amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; Es un buscador, pero además tiene multitud de herramientas con las que ayudarnos: alertas, gmail(correo). google+ (red social), página de inicio individualizada, google académico, agregador RSS...&lt;/div&gt;
&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://blogrespira.blogspot.com/feeds/9180562223412126118/comments/default' title='Enviar comentarios'/><link rel='replies' type='text/html' href='http://blogrespira.blogspot.com/2012/04/web-20-y-medicina-herramientas.html#comment-form' title='0 comentarios'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/950616212044414228/posts/default/9180562223412126118'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/950616212044414228/posts/default/9180562223412126118'/><link rel='alternate' type='text/html' href='http://blogrespira.blogspot.com/2012/04/web-20-y-medicina-herramientas.html' title='WEB 2.0 y Medicina II: Herramientas'/><author><name>Raúl</name><uri>http://www.blogger.com/profile/14709690265626598608</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-950616212044414228.post-3563033454639078881</id><published>2012-04-23T07:31:00.000-07:00</published><updated>2012-04-23T07:31:35.973-07:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="informacion"/><category scheme="http://www.blogger.com/atom/ns#" term="web 2.0. internet"/><title type='text'>WEB 2.0 y Medicina: ¿QUÉ ES LA WEB 2.O?</title><content type='html'>&lt;br /&gt;
&lt;div class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;https://encrypted-tbn0.google.com/images?q=tbn:ANd9GcQeVip_RjvrzTLbFdcT9sHPGYily9cwGzRk4PQ7rd7WcGVST2fv&quot; imageanchor=&quot;1&quot; style=&quot;clear: left; float: left; margin-bottom: 1em; margin-right: 1em;&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;https://encrypted-tbn0.google.com/images?q=tbn:ANd9GcQeVip_RjvrzTLbFdcT9sHPGYily9cwGzRk4PQ7rd7WcGVST2fv&quot; /&gt;&lt;/a&gt;&lt;br /&gt;
&lt;div style=&quot;text-align: justify;&quot;&gt;
Internet abrió unas posibilidades inifnitas en el acceso a
la información, pero desde inicios del siglo XXI, ya no es complicado publicar
y cualquier persona puede hacerlo. Tim O´Really en el año 2004 acuña el término
de web 2.0 refiriéndose al sujeto como ente activo en el intercambio, consumo y
publicación de información.&lt;/div&gt;
&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot;&gt;
&lt;div style=&quot;text-align: justify;&quot;&gt;
Características:Es publicado en la web, aprovecha la
inteligencia colectiva, gestión de bases de datos, simplicidad...&lt;/div&gt;
&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot;&gt;
&lt;div style=&quot;text-align: justify;&quot;&gt;
La web 2.0 da cabida a multitud de herramientas: Blog.
Twitter,Facebook, Myspace, Linked-In, Youtube, Flickr.&lt;/div&gt;
&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://blogrespira.blogspot.com/feeds/3563033454639078881/comments/default' title='Enviar comentarios'/><link rel='replies' type='text/html' href='http://blogrespira.blogspot.com/2012/04/web-20-y-medicina-que-es-la-web-2o.html#comment-form' title='0 comentarios'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/950616212044414228/posts/default/3563033454639078881'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/950616212044414228/posts/default/3563033454639078881'/><link rel='alternate' type='text/html' href='http://blogrespira.blogspot.com/2012/04/web-20-y-medicina-que-es-la-web-2o.html' title='WEB 2.0 y Medicina: ¿QUÉ ES LA WEB 2.O?'/><author><name>Raúl</name><uri>http://www.blogger.com/profile/14709690265626598608</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-950616212044414228.post-2890696892058977296</id><published>2012-04-13T12:57:00.000-07:00</published><updated>2012-04-13T13:15:46.324-07:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="broncoscopia"/><category scheme="http://www.blogger.com/atom/ns#" term="tecnicas"/><title type='text'>BRONCOSCOPIA</title><content type='html'>&lt;span style=&quot;text-align: justify;&quot;&gt;Es un procediemiento que permite la exploración de la
tráquea y el árbol bronquial. Para ello se utiliza un aparato que se llama
broncoscopio. Existen 2 tipos de broncoscopios:&lt;/span&gt;&lt;br /&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;margin-left: 36pt; text-align: justify; text-indent: -18pt;&quot;&gt;
&amp;nbsp; &amp;nbsp; &amp;nbsp;&lt;b&gt;&lt;span style=&quot;font-size: 7pt;&quot;&gt;&amp;nbsp;&lt;/span&gt;Rígido :&lt;/b&gt; Es un tubo rígido, del que hay diferentes tamaños,
con un sistema de iluminación. Se procede a la intubación del paciente con ese
tubo&lt;br /&gt;
&lt;div style=&quot;text-align: center;&quot;&gt;
.&lt;img src=&quot;data:image/jpeg;base64,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&quot; style=&quot;text-indent: -18pt;&quot; /&gt;&amp;nbsp;&lt;br /&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;margin-left: 36pt; text-align: justify; text-indent: -18pt;&quot;&gt;
&lt;a href=&quot;data:image/jpeg;base64,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&quot; imageanchor=&quot;1&quot; style=&quot;clear: left; float: left; margin-bottom: 1em; margin-right: 1em;&quot;&gt;&lt;img border=&quot;0&quot; height=&quot;143&quot; src=&quot;data:image/jpeg;base64,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&quot; style=&quot;text-indent: -18pt;&quot; width=&quot;200&quot; /&gt;&lt;/a&gt;&amp;nbsp; &amp;nbsp; &lt;b&gt;&amp;nbsp;Flexible:&lt;/b&gt; Es un aparato que, a través de unos haces de fibra
óptica, se consigue ver lo que hay frente a&amp;nbsp;
la punta del aparato.&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
La broncoscopia sirve para tanto para estudios diagnósticos
( tumores, lesiones&amp;nbsp; intrabronquiales,
hemoptisis, toma de muestras respiratorias....) como medidas terapéuticas (
tapones bronquiales, cuerpos extraños, tratamientos intrabronquiales
(crioterapia, láser...)&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;br /&gt;
El paciente suele venir con miedo. Habitualmente ha
escuchado que es una técnica dura. Hay que explicarle que no es dolorosa. Sí,
existen molestias, y la peor es la irritación que produce el broncoscopio a su
paso por la vía aérea. Los pacientes lo describen como una sensación de ahogo,
de picor que le hace toser. Es recomendable usar anestesia tópica para
disminuir la sintomatología y una leve sedación para tranquilizarlo, el
midazolan tiene la ventaja de éste efecto, pero además produce pérdida de
memoria (no recuerdan la prueba)&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;iframe allowfullscreen=&#39;allowfullscreen&#39; webkitallowfullscreen=&#39;webkitallowfullscreen&#39; mozallowfullscreen=&#39;mozallowfullscreen&#39; width=&#39;320&#39; height=&#39;266&#39; src=&#39;https://www.youtube.com/embed/g0y2awvdJIw?feature=player_embedded&#39; frameborder=&#39;0&#39;&gt;&lt;/iframe&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
Tiene riesgos, aunque son mínimos. Éstos aumentan con el
estado previo del paciente. A los enfermos cardiológicos:&amp;nbsp;infartos, arritmias.
Puede producirse hemorragias, desaturaciones...&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
Habitualmente la prueba la hace un médico asistido por
enfermera y auxiliar (aunque esto depende de los recursos). Se necesita una
monitorización de la frecuencia cardíaca y la saturación de oxígeno.&amp;nbsp;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
La técnica hay que hacerla con oxígeno suplementario&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot; style=&quot;text-align: justify;&quot;&gt;
&lt;br /&gt;&lt;/div&gt;
&lt;div class=&quot;MsoNormal&quot;&gt;
&lt;br /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://blogrespira.blogspot.com/feeds/2890696892058977296/comments/default' title='Enviar comentarios'/><link rel='replies' type='text/html' href='http://blogrespira.blogspot.com/2012/04/broncoscopia.html#comment-form' title='0 comentarios'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/950616212044414228/posts/default/2890696892058977296'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/950616212044414228/posts/default/2890696892058977296'/><link rel='alternate' type='text/html' href='http://blogrespira.blogspot.com/2012/04/broncoscopia.html' title='BRONCOSCOPIA'/><author><name>Raúl</name><uri>http://www.blogger.com/profile/14709690265626598608</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-950616212044414228.post-2640505562387784188</id><published>2011-06-05T08:34:00.000-07:00</published><updated>2011-06-05T08:34:00.657-07:00</updated><title type='text'>Comentarios</title><content type='html'>He habilitado la opción para que podáis publicar comentarios. Decidme que os parece, respondedme las preguntas y preguntad y proponed temas. Estamos abiertos a todo.</content><link rel='replies' type='application/atom+xml' href='http://blogrespira.blogspot.com/feeds/2640505562387784188/comments/default' title='Enviar comentarios'/><link rel='replies' type='text/html' href='http://blogrespira.blogspot.com/2011/06/comentarios.html#comment-form' title='0 comentarios'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/950616212044414228/posts/default/2640505562387784188'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/950616212044414228/posts/default/2640505562387784188'/><link rel='alternate' type='text/html' href='http://blogrespira.blogspot.com/2011/06/comentarios.html' title='Comentarios'/><author><name>Raúl</name><uri>http://www.blogger.com/profile/14709690265626598608</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-950616212044414228.post-7243322151087055718</id><published>2011-06-02T06:48:00.000-07:00</published><updated>2011-06-02T06:55:35.942-07:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="epworth"/><category scheme="http://www.blogger.com/atom/ns#" term="poligrafía"/><title type='text'>roncador, hipersomnolencia II</title><content type='html'>&lt;div class=&quot;MsoNormal&quot; style=&quot;margin: 0cm 0cm 0pt; text-indent: 18pt;&quot;&gt;&lt;a href=&quot;http://blogrespira.blogspot.com/2011/06/roncador-hipersomnolencia.html&quot;&gt;PRIMERO LEER LA PRIMERA PARTE&lt;/a&gt;&lt;br /&gt;
El neumólogo escuchó su relato con interés. Le tomó la tensión arterial que estaba ligeramente elevada. Le revisó y descartó en una analítica que tuviera un hipotiroidismo, además comprobó que el colesterol estaba ligeramente elevado. Le pasó el test de Epworth y el resultado fue 16&lt;/div&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;margin: 0cm 0cm 0pt; text-indent: 18pt;&quot;&gt;Entonces le miró y le dijo:&lt;/div&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;margin: 0cm 0cm 0pt 36pt; mso-list: l0 level1 lfo1; tab-stops: list 36.0pt; text-indent: -18pt;&quot;&gt;-&lt;span style=&quot;font-family: &#39;Times New Roman&#39;;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;Luis, tenemos que ver que es lo que pasa cuando duermes. Te voy a hacer una poligrafía.&lt;/div&gt;&lt;div class=&quot;MsoBodyTextIndent&quot; style=&quot;margin: 0cm 0cm 0pt;&quot;&gt;Esa noche el paciente se llevó un aparato a casa que registraba la saturación de oxígeno, los movimientos torácicos y abdominales, los ronquidos, el pulso, la ventilacióny la posición.&lt;/div&gt;&lt;div class=&quot;separator&quot; style=&quot;clear: both; text-align: center;&quot;&gt;&lt;a href=&quot;https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgaV7VlNVdO6tm_9CkRPg4oT0CITW76eoxDv1PoESi9yCWvqUugH_a5-xNtS7Fp2fsKBSbS6RBnHHhpwqfX2c2nDrzmacBJxC9t2uqDSoyFiCL98Hx5qkP8LcbWe6cBQOWbd5URcu9s/s1600/clip_image002.jpg&quot; imageanchor=&quot;1&quot; style=&quot;margin-left: 1em; margin-right: 1em;&quot;&gt;&lt;img border=&quot;0&quot; height=&quot;172px&quot; src=&quot;https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgaV7VlNVdO6tm_9CkRPg4oT0CITW76eoxDv1PoESi9yCWvqUugH_a5-xNtS7Fp2fsKBSbS6RBnHHhpwqfX2c2nDrzmacBJxC9t2uqDSoyFiCL98Hx5qkP8LcbWe6cBQOWbd5URcu9s/s320/clip_image002.jpg&quot; t8=&quot;true&quot; width=&quot;320px&quot; /&gt;&lt;/a&gt;&lt;/div&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;margin: 0cm 0cm 0pt 18pt;&quot;&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;margin: 0cm 0cm 0pt 18pt;&quot;&gt;&lt;span style=&quot;mso-tab-count: 1;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;El resultado fue:&lt;/div&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;margin: 0cm 0cm 0pt 36pt; mso-list: l0 level1 lfo1; tab-stops: list 36.0pt; text-indent: -18pt;&quot;&gt;-&lt;span style=&quot;font-family: &#39;Times New Roman&#39;;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;Índice de apnea-hipopnea (IAH)= 63&lt;/div&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;margin: 0cm 0cm 0pt 36pt; mso-list: l0 level1 lfo1; tab-stops: list 36.0pt; text-indent: -18pt;&quot;&gt;-&lt;span style=&quot;font-family: &#39;Times New Roman&#39;;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;Índice de desaturación de Oxígeno (ODI 3%)= 70&lt;/div&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;margin: 0cm 0cm 0pt 36pt; mso-list: l0 level1 lfo1; tab-stops: list 36.0pt; text-indent: -18pt;&quot;&gt;-&lt;span style=&quot;font-family: &#39;Times New Roman&#39;;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;TC90= 4%&lt;/div&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;margin: 0cm 0cm 0pt 36pt; mso-list: l0 level1 lfo1; tab-stops: list 36.0pt; text-indent: -18pt;&quot;&gt;-&lt;span style=&quot;font-family: &#39;Times New Roman&#39;;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;Saturación media: 92%&lt;/div&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;margin: 0cm 0cm 0pt 36pt; mso-list: l0 level1 lfo1; tab-stops: list 36.0pt; text-indent: -18pt;&quot;&gt;-&lt;span style=&quot;font-family: &#39;Times New Roman&#39;;&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;Saturación más baja: 80%&lt;/div&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;margin: 0cm 0cm 0pt 18pt;&quot;&gt;No había diferencias en el IAH según las diferentes posiciones.&lt;/div&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;margin: 0cm 0cm 0pt 18pt;&quot;&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div class=&quot;MsoNormal&quot; style=&quot;margin: 0cm 0cm 0pt 18pt;&quot;&gt;¿Cuál es el diagnóstico? ¿Cuál el Tratamiento?. Dejarlo en los comentarios.&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://blogrespira.blogspot.com/feeds/7243322151087055718/comments/default' title='Enviar comentarios'/><link rel='replies' type='text/html' href='http://blogrespira.blogspot.com/2011/06/roncador-hipersomnolencia_02.html#comment-form' title='0 comentarios'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/950616212044414228/posts/default/7243322151087055718'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/950616212044414228/posts/default/7243322151087055718'/><link rel='alternate' type='text/html' href='http://blogrespira.blogspot.com/2011/06/roncador-hipersomnolencia_02.html' title='roncador, hipersomnolencia II'/><author><name>Raúl</name><uri>http://www.blogger.com/profile/14709690265626598608</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgaV7VlNVdO6tm_9CkRPg4oT0CITW76eoxDv1PoESi9yCWvqUugH_a5-xNtS7Fp2fsKBSbS6RBnHHhpwqfX2c2nDrzmacBJxC9t2uqDSoyFiCL98Hx5qkP8LcbWe6cBQOWbd5URcu9s/s72-c/clip_image002.jpg" height="72" width="72"/><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-950616212044414228.post-3566395095234360411</id><published>2011-06-01T10:00:00.000-07:00</published><updated>2011-06-02T06:50:05.294-07:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="apneas"/><category scheme="http://www.blogger.com/atom/ns#" term="cansancio"/><category scheme="http://www.blogger.com/atom/ns#" term="cefalea"/><category scheme="http://www.blogger.com/atom/ns#" term="hipersomnolencia"/><category scheme="http://www.blogger.com/atom/ns#" term="nicturia"/><category scheme="http://www.blogger.com/atom/ns#" term="roncador"/><title type='text'>roncador, hipersomnolencia</title><content type='html'>&lt;div style=&quot;text-align: justify;&quot;&gt;Juan es camionero, la falta de ejercicio y las grandes sentadas conduciendo, además de esos bares de carretera donde se come con tanta grasa, han hecho que engorde de manera importante. &lt;/div&gt;&lt;div style=&quot;text-align: justify;&quot;&gt;Hacía 15 días que no veía a su mujer, esa noche se fueron a la cama pero él se quedó dormido. Al despertar por la mañana le dolía la cabeza, estaba cansadísimo. Se levantó y fue al salón, se sorprendió al ver a su mujer dormida en el sofá.&lt;/div&gt;&lt;div style=&quot;text-align: justify;&quot;&gt;- Juan, no podía con los ronquidos, además se te para la respiración. ¡Me va a dar un infarto!&lt;/div&gt;&lt;div style=&quot;text-align: justify;&quot;&gt;Aquella mañana la tenía libre y se fue a jugar al mus con unos amigos, al sentarse se quedó durmiendo. Sus amigos le despertaron y le acompañaron a casa, y al llegar al sofá otra vez dormido.&lt;/div&gt;&lt;div style=&quot;text-align: justify;&quot;&gt;La verdad, es que ya durante las largas horas de carretera solía llevar un termo de café y se había sorprendido dando alguna cabeza.&lt;/div&gt;&lt;div style=&quot;text-align: justify;&quot;&gt;Al día siguiente seguía igual, había orinado 2 ó 3 veces esa noche, seguía cansado.&lt;/div&gt;&lt;div style=&quot;text-align: justify;&quot;&gt;-Tú no coges el camión- dijo su mujer&lt;/div&gt;&lt;div style=&quot;text-align: justify;&quot;&gt;Juan tenía que hacer algo y recurrió a un neumólogo que le mandó una prueba.&lt;br /&gt;
¿Puedes poner en Comentarios &lt;a href=&quot;http://blogrespira.blogspot.com/2011/06/roncador-hipersomnolencia_02.html&quot;&gt;como seguiría&lt;/a&gt;?&lt;/div&gt;&lt;div style=&quot;text-align: center;&quot;&gt;&lt;a href=&quot;http://www.google.com/imgres?imgurl=https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEir0I3aI1MX-AZBwoXxhMDzrwh7o3W-Y5sPnLAbUU2qfjY8vSUxQZ93IRKjWv1_v-vs6d3wSafv9-NFjMJkwGo3x3cPYcNUhLxjaQfvQ_y3V7TUlJuxstsfQIXdxM2K0MJoXdEYcXVKJZI/s200/tablesleep.jpg&amp;amp;imgrefurl=http://aadsm.blogspot.com/2010/04/language-of-sleep-popular-screening.html&amp;amp;usg=__h7_o_Ym8A9keaAEmxtipfbbSyXY=&amp;amp;h=100&amp;amp;w=150&amp;amp;sz=5&amp;amp;hl=en&amp;amp;start=5&amp;amp;sig2=Bro0JUvrgHC7a0HlKbdfLQ&amp;amp;zoom=0&amp;amp;um=1&amp;amp;itbs=1&amp;amp;tbnid=gpr1kP9RV2zeNM:&amp;amp;tbnh=64&amp;amp;tbnw=96&amp;amp;prev=/search%3Fq%3Dosa%2Bepworth%2Bfat%26um%3D1%26hl%3Den%26sa%3DN%26biw%3D1259%26bih%3D754%26ndsp%3D20%26tbm%3Disch&amp;amp;ei=0XPmTbfDB4fD8QPO7_2JCg&quot; id=&quot;apf4&quot;&gt;&lt;img height=&quot;132px&quot; id=&quot;ipfgpr1kP9RV2zeNM:&quot; src=&quot;http://t1.gstatic.com/images?q=tbn:ANd9GcTyd7uAoJ-COnzd24SODE11j84snVDO_VE1Ia0kEHyl2_mANgV5&quot; style=&quot;border-bottom: #ccc 1px solid; border-left: #ccc 1px solid; border-right: #ccc 1px solid; border-top: #ccc 1px solid; padding-bottom: 1px; padding-left: 1px; padding-right: 1px; padding-top: 1px; vertical-align: bottom;&quot; width=&quot;200px&quot; /&gt;&lt;/a&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://blogrespira.blogspot.com/feeds/3566395095234360411/comments/default' title='Enviar comentarios'/><link rel='replies' type='text/html' href='http://blogrespira.blogspot.com/2011/06/roncador-hipersomnolencia.html#comment-form' title='0 comentarios'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/950616212044414228/posts/default/3566395095234360411'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/950616212044414228/posts/default/3566395095234360411'/><link rel='alternate' type='text/html' href='http://blogrespira.blogspot.com/2011/06/roncador-hipersomnolencia.html' title='roncador, hipersomnolencia'/><author><name>Raúl</name><uri>http://www.blogger.com/profile/14709690265626598608</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry></feed>